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DNA which can in two thus .::mr.Wlrln gene ",vr\r/=".:<:ir.n in are 
termed shuttle vectors. Escherichia are used 
in many areas of mvcot>acterllal .. " .. :"",,,, .. rh 
ru:lT'nr.n",r\"'<:IC: and the np""".rm 
elucidation of mycot>adterial 
vaccines. These E. coli-of recombinant myc:obactcaria 
mycot)adterial shuttle vectors n .. "",,,"'" a convenient mY"COl:taCl:erlial ",'\(n.-"""",inn since 
recombinant gene within my'colJacterla 
can be carried out in E. 
and grows <:innifir:;o"tlv 
an "" .... ,."". which is far easier to level 
i=ni[<:n''n:;ol E. shuttle vectors rnr,t:;oj,ninll'1 the 
DAI.5000··0elrivE!<1 mlva)ba,cterial .. o",lirr\f' are the most 
characterised and poor levels of recombinant To 
n.-nnorl"'",<: of the recombinant gene and elements within E. 
shuttle vectors have been to determine and levels. This 
aimed to whether the mycot>adterial "~'nlll~nn may also a role. The common 
in 
truncated rap gene, on/'nrli .... " 
shuttle vectors contains the 
and the and genes 
which code for essential reJ;IIICinlCln nlrn1'''·,n<: -';n,>r,T"r a~5pects of this 
.-on,lIrrm were identified as fV\T,onl","::>I 
and were modified ""rrnrn.nni'" 
copy number mutation within 
and increase recombinant 
The modifications included: 
inclusion of the entire rap 
gene and its UUIClIl"'C tr::>nc:rnl.,ti",n terminator and introduction of an 
terminator While none of the modifications 
inclusion of the copy number mutation and the entire rap gene both caused a <:lnn,l"lr::ll .. \I· 
increase in copy number. In the rap gene modification as well as of 
the terminator increased of the recombinant gene, the green 
fluorescent observed increases in copy number nrr\\"t'lI", 
for the modified in E. shuttle 
vector in the absence of antibiotic was upon 
inclUSion of the full rap gene in My.col'BQ':enum sm,eQr.nal7sand insertion of the 
tr::lllnC!rrint'inn terminator in both M. sm'eolnalts and Mycol:oaateriilm bovis Bacille cal mette-
results a correlation between 
",vr",,,,,:<:,r.n levels and reduced Further is increased recombinant 
necessary to determine whether ';:>LCIIJ'II'LY in vitro may be 
a to control recombinant 
overcome use of 
nnl~imii=t'jnn of 
the recombinant gene. If this could be :::Irt"o'I"'1"I the modifications identified in this 
which increased may have in the 
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1.1. APPLICATIONS OF E. COLI-MYCOBACTERIAL SHUTTLE VECTORS 
term is derived from their 
in both. Escherischia COII"m,'COltlacten 
research to allow the 
includes research focused on the elucidation of 
Oe\Ielooment of vaccines as a .... " •• ,,<>,"V vehicle. Dual reDlicative r:::'r.:::.r,'hl 
of E. COl,f.ml{COlJacterlal shuttle vectors in both E. coli and mvcot>adterlal 
to be carried out in E. and recombinant gene ovr,ro.,,,irln within 
is necessary since there exist a number of difficulties associated 
with "'''''''01-;..-
to culture in 
For are difficult 
slow and t4Olnit1""nrv to ;o,nr,r4Olr,;o,r", 
& of myc:oo,actc:ma their 
for the cell walls which demand 
E. in introduction and extraction of "onotir 
contrast to is rnr .. ,irlroy", better suited to recombinant purposes as it is far 
easier to "onol"ir level and grows faster. Thus E. coli-
my<:obi:lctE!rial shuttle vectors nrnlJit140l a convenient that has 
1.1.1. ELUCIDATING MYCOBACTERIAL PATHOGENESIS 
The main mycotladterial n:3I"h,\,.,,,,.,,,, ",I"torn"n humans are My,co(,'laQ'eri,um U/L~IT.uIl)'!N,"i. the 
causative of tuberculosis which causes Hansen's 
disease (fnlrm~'rlv ,~~,.~~., 'r'~~~,~1 
for elucidation of 
biochemical and 
develol:lmelnt of E. coli~mycoblactc=rial 
norl"'TI,~C:: as an additional tool for ,nrl,"'I"C:1~::I 
Before the advent of a n",,,,,,tir 4Ol"" ... r4Ol'=c::ir ..... 
In order to 
"'''',.,lr_=t1 within 
the effect of eno,rit';r myc:Obact4eria need to be 
,,-n::lthnnl"nir myc:obactceria hosts. Both non-virulent My,cOl.1aClrenum bovis 
Bacille MY'COl.'laClrenUm smoolnatis fulfil this and are 











with n:::.TI"IN,,,,,,,,.- M. tuberculosis a few rl",l",ti'~n<: is 
identical to M. bovis from which it was 
BeG offers an environment in which to 
mycot,adterial genes as genes are a near identical h::. ... '!<n.'n, to those of 
their natural hosts. M. grows cinnifir::,.,t!" faster than other mycot>actel'1la as 
it is often used as a mycotladterial model to of antjcitlatE!d 
results for et 
Numerous my,cot'ad:enal n::,I"I"IIV1",n",,,'ic: studies have E. shuttle 
vectors to express genes in BeG and M. Such studies 
have contributed of virulence. This increased 
KnOWle,oae of mYI:obactE~rial 
in 
and in 
has been eXllioited in the of vaccines 
mY<Do.attE!nal di~~a~=1 in II1n""",",\,,,nn the 
transmission new 
1.1.2. RECOMBINANT MYCOBACTERIA AS VACCINE VECTORS 
BeG and M. Sffleqt:nallS are at n .. ".""".,t as live vectors for vaccines ::.n;~,n'~T 
and other .... ::.I·hn.n",.,c: 
ap[lealilnQ recombinant mycot>acten 
The reasons BeG and M. 
vaccine vectors are described below. 
1.1.2.1. Recombinant BCG Vaccines 
There exist numerous o:.",h"",nt·",,,,,,,, to de"elc)oirlQ BeG-based vaccines. BeG is the current 
vaccine for TB and forms of the World Health 
on Immunisation et 
networks are ;;;0'1'",,,,,,,,,,,,, established to tr:'HnC:"""'rt and administer BeG. From a 
BeG vaccination can be 
three billion doses 
at birth and few side effects have been ... ",n.nrt,>rI from over 
since 1948. Furthermore it can be for per dose 
This cost-effectiveness makes BeG-based vaccines attractive 
for de"elc)pirlg nations which bear much of the burden of infectious disease. In terms of the 
elicited immune response, BeG functions as a and is able to n&>r<:ic:t",ntlv 
stimulate the immune as it .. ", .... Ii.-::.t",<: &. 
Recombinant genes from a number of and """',",::"",1"11- n:>l"l"Inn,:>nc have been 











vaccines. While it is that rBCG vaccines may be used to nr""JII"I'" dual 
TB and other the BCG vaccine in circulation limited 
.Inv,n::>,nl adult TB. Since TB in adults is for the 
""'''''i"ri,1'\1 of TB-related there is an obvious need for more effective TB vaccines. Two 
of the five alternative TB vaccine candidates in clinical trials utilise E. coli-
my,cotladteri,al shuttle vectors as rl>t'1nmhi versions of the BCG vaccine 
recombinant BCG30 and AureC rBCG exhibited 
Ifnr,rn'1Pr1 :::Intin""nirilt\l and to standard BCG 
I trials. 
1.1.2.2. Recombinant No sm,egm.a,tisVa4cciI1es 
M. is as an additional vaccine vector candidate to BCG. 
Dnt'.::>rir,n the immune M. smealnatis is processed m:::l,-rn, ... I"I::>n.::>", far faster 
than BCG In of its lack of recombinant M. 
Sm,f:!QlnallS has been shown to be 
immune responses et 
recombinant :;ony'.n<:l,n_c:n<>,_.Tlr 
in cases where a more 
immune response is desirable over a 
"""I"'1 ..... i<,i .... ", vaccine vector. 
n.:>r'<;ic:t'.:>nt response, M. ,c;m,ear,nall,C; appears a 
1.2. TYPES OF E. COLJ:.MYCOBACTERIAL SHUTTLE VECTORS 
Two niH'ori.,n " ..... n"""'r:I"I"''' are in order to achieve gene I!>YI"II"I!>,e;c::ifln in 
The first involves introduction of the recombinant genes into the mycot)ad:eri,al 
host and int~>nr::.til"'.n into the host chromosome via int."nr,:::Iti~I':> shuttle 
vectors. The second utilises "'':>'''_ .. onl 
the host and express them. 
"'n .. ",m,:::I1 shuttle vectors to introduce genes into 
1.2.1. INTEGRATIVE E. COU-MYCOBACTERIAL SHUTTLE VECTORS 
In 1987 a shuttle of both nl::l<::mir1 reolicaltion in E. coli and 
in M. and BCG was no,~i .... r'orI 
a chimaera of TM4 my,col:lacteri()phage DNA and an E. 
pa(:Ka!~ea into is that it allows 
efficient infection of my,cob!act,eria characterised resilient cell which otherwise 











vectors have been further Imrlrn,jAn upon the inclusion of antibiotic resistance genes to 
allow selection of desired transformants (c:.rl;:onln",r et In from 
alternative genes have been used to 
enable between the attP and attB attachment 
sites & These include use of the L1 mycot)acteriiop!ha~Je r~'nli'~nn in the 
ntAnr:'I'~iv'" vectors et et 
as well as LS in the series 
re[Jtea1tedlv shown that int.""r",1-',,,,, shuttle vectors 
are after 30 1"I""""" .. ::ot'"ne in the absence of antibiotic sel,ectlon 
no .. 'n"'~'" et at showed that 100% of 
rotavirus VP6 in BeG retained antibiotic resistance and np"",tir after 100 
Mederle demonstrated antibiotic resistance retention and "",.10I-i,.. s:!'ahilltv in 
up to 100% of Ob""t-oelrlVE!O ;n,h>rlr;:ot"'IP vectors Povr,rPo<:c, SIV-l gag and nefin BeG. Vector 
staDIII1r:.t is the of recombinant vaccines when 
in which the vector has been lost or mutated may take over 
cultures. De.SDI1te "iFfo."n,., ",,.1\,,::>,.,,1-,,,,.,,,, of levels of ,.,,,,,101'1" 
vectors in1-£"" .. ,:>1-", 
levels. For ;nc1';:on('", 
n::uL.'v<::,v restricts recombinant gene pvr,,".,.'~c'rln 
... ",nnrt&>rI that 0.16% of total in BeG rpn"''''CJI''nt~>rI 
recombinant SIV-l and Nef when vectors were utilised 
With gene levels of up to 15% of total been 
"'''.'''''',:e,r,1'\ levels attained via ,nn,nr: .. TI\,,., vectors fall """dc:to"1-I,, within the lower 
end of the range. 
1.2.2. EPISOMAL E. COLI-MYCOBACTERIAL SHUTTLE VECTORS 
The first E. shuttle vector was in 1988 et 
at. contained an antibiotic resistance selectable marker in 
addition to chimaeras of E. coli and The 
,""::>ern,,, .. ".nli,-nn was derived from a natural MYCOl1aClr:enum fortuitum nl::o',mlln 1,J, ........ 'vvV'. and 
its r".n,li,..::.t-i""n is rnrnrl'"lI"InlV termed the mycotlacterial It 
that the ori instead be named 
l"",n,lIrr.n may be a misnomer since the I"pn,lirrln does not facilitate mycotladterial rE!plilcation 
but rather within et In accordance with 
standard this refers to the as the 











have been ovr",....'tor! to "o,~o .. ",to alternative ",n.""" • .,.,,,,, E. COII"m"COIDactenial shuttle 
those based on the IJML.JV\/V m,ycc10a(:terla ... ""nili ... ,..n remain the most ovi,ond"ol" 
this review concentrates on further 
nnf'imi=tinn of IJML..J\/UV mYicot.ad:erl.al r~'nlif'nl'-hrlc:.:>rI vectors. 









Adapted from similar Table Parish & Stoker, 2001 
The .n(1,""""'n(1,,, .... " .. "" .... Ii ... ;.thJ'''' CilDalcn:v of "'1"'1;,,,,,,,,.,.,,,,1 E. coJ,li-mvalbacterial shuttle vectors means 
that are not limited to copy number. This allows levels of recombinant gene 
"'V'''·''''=c:',..,n to reach c:i .... n.f".,..:::or'f"I\I ....... ".:::Of"., ... levels than those achieved via nf""." ... :.I"I\,o vectors. 
The recombinant gene level of 15% of total mvcotlaC1:enal was 
attained for from an vector :::.n,no,-m: ..... n et 
f'funn:::o ... ic:nn to an recombinant SIV-1 and Nef 
were "'VI ..... "'<:<:&./1 at a seven-fold n .. ~·,:m"r level in an ",nic:n,nrll vector based on the U .... 'L ... 'UU 
M"",r(orl", et 
vectors have 
stable than 'nt,,,,,, ... ::.+h,,o vectors. For 
capi:lDle of 
been noted as 
the same Mederle 
recombinant gene 












that as few as 0.1% of oni"'''''"::.1 vectors were 1"10''"1",,",,,..::>11,, stable while all in"':o.n .. ","i"o vector 
enl: IIV:?IiPlnrS maintained 100% staOill1"){ 
1.3. OPTIMISATION OF EPISOMAL E. COLI-MYCOBACTERIAL SHUTTLE VECTORS 
BY COMPONENT 
An ideal E. COII~ml{COllJactenial shuttle vector would allow for the of levels of 
recombinant while To this have been made to 
",ni':nml~1 E. shuttle vectors the 
selectable m~lir",1" the the recombinant and the of the 
... n~.JV"V rt:'niit-nn utilised. 
1.3.1. THE SELECTABLE MARKER 
To facilitate the identification of recombinant a selectable marker of sorts was 
to be in E. shuttle vectors Jr. et 
Antibiotic resistance markers were for this purpose because of their well· 
documented in E. coli and other bacterial While a 
an antibiotic resistance marker would have been 
ideal based on its in no such antibiotic resistant was 
available. an artificial antibiotic marker was which needed to meet two 
conditions. the antibiotic needed to be effective as a number of 
used antibiotics are unable to the cell surface et 
and a number of have antibiotic resistance. In 
the antibiotic needed to be stable to ensure that it remained effective for the 
duration of the extended time for cultivation of cl .... ' .. '." .. n'.Ali".n ITIYCC)02IctE!rIa 
were the first to show that ... hl,n .. ",rnr.honil"nl 
used to In",nT'11rv M. smoo('natts and BeG transformants. The rhl''1I''~mn 
gene and two \(~r'~n'vr,in resistance genes; 
and nor."",,,,,.., ~~r,~n'vrln nihnc:nh''1t~~nc~~~=II 
were InVlestloat:ea. In,..;~mr'h""nir,nl resistance was ';>"'L'='~"''"' 
unsuitable selectable marker as there was a risk of transfer of 
could be 
5 and 903 
deemed an 
resistance between mv'col)acteria Similar concerns about transferal of antibiotic resistance to 











favoured over n<>r,"u,r.n/v:::.n:>rn\lrin nll"l,.,,,ntv,f<r:>ncr,:>y::>,,,,, II which 
n",(\m\lrln and I(;::,r\;::,nr'ivr!n et Radford and 
used the resistance gene, in an E. shuttle vector to 
<:mpmnal'it;; and BeG recombinants. A number of alternative resistance 
markers such as and have since been used but have 
either lowered transformation unreliable &. et 
the use of counter-selectable m::> .. ",,,,,,,, such as 
as an for gene Since it 
allows simultaneous selection of hornoloo()uS recombination and vector loss et 
et At and are the antibiotic 
resistant genes used most as selectable markers within E. 
shuttle vectors. vectors used in this include the "'''''ArT1Vn,n 
resistanoe gene to reflect a utilised antibiotic marker. 
within E. coli-
&. 
co"~mycC)bacterial shuttle vectors rlo,."",,,i,,, 
on the nr('lm(\tpl"<: affect the d"1"~>nl'llrh and of gene 
Sinoe coJ~myc()bacterial shuttle vectors is 
may offer a c:tl";:.I"",(',v 
other an upper limit for nnl~'m"" ""lfn .. ",c:c::inn 
On the 
above which ",vr\I""":c:i",n may 
cause a metabolic burden which would be QisaQ\lantaQeOlJS The 
n .. r.m("t",,. ;;orr,'",,,,, may be limited 
is elicited their 
recombinant vaccines 
::>"t""''',n at the time of exposure to the immune 
response. A ",.r,mr,f<", .. which is inducible in vivo may fulfil this 
The immune response :::In,~in,::t 
for 
of the recombinant 
m",.,.,\"O the elidted immune 
An extensive range of Dos;sib1le nlrnnrlntil'rc: have been for use in E. cOl~mYCC)bacterjal 











Table 1.2. Source references of nr."lI'II'IIftl',1I01l'C I"ftlmll1nftlnlv utilised in E. coli-
(l antigen 















1.3.2.1. Heat Shock Protein Promoters 
Heat shock nrn,mn!'j:>rc: and 
in my,cobact,eria 






BeG; M, smegmalis 
BeG; M. smegmalis 
BeG 
(Matsuo et al, 1990) 
(Winter eta!, 1991) 
(Stover et al, 1991) 
(Aldovini 11 Young, 1991) 
(Murray et al, 1992) 
(Stover et al, 1993) 
(Oellagostin et aJ, 1993) 
(TImm et al, 1994) 
(Via et al, 1996) 
the resloective j:>vr\r",,:c:jl'l,n of heat shock 
heat shock 
conditions of extreme t"'n~n<>":::Ih levels of 
<:;Y'UIOIL<:;\..I in order to elicit an aOiamwe stress response 
As the heat shock are able to drive were 
chosen as to drive gene "'vr"'j:>,~c:jr\n coli~m\(colbacteriial shuttle vectors. 
in my«:obactleria 
and the demonstrated n"~""!""r nlen ... ,n!",,, ... than the 18kDa 
::.nt·ln".n ,."en ... ,,.,!",,, ... in both M. smegt:nalis ,., .... ", .. ," .,.11"1:::11",::>,.,1 et 
the of these to the 
environment rj:>rl .. p<;;::>nlr~ an ;:1(1\1:::1n,t:::ll'llp upon pnlrpri,nn the in vivo environment of the immune 
when the induction of levels of gene is desirable & 
In an in vitro rnrltj:>'II't j:>vr,,·j:>,:c::;r.n levels in response to 
conditions may be olsam/an,tacleous. This is because ",vl, .. """c::;,.,n levels 
of a :::Inl·ln".n can be toxic to the mycot>aCltenal the 
has been shown to contribute in a number of studies 
et Nonetheless heat shock 
n .. r .... ·v'h"'·" remain ",ytpn<:iViO.lv utilised within E. COlf-mVC()Oaa:enal shuttle vectors. The 
rn'Ylrr,nnlv in the series of E. cmf-mvc()Oaa:e:nal shuttle 
vectors. As a result of its the was utilised as the 










1.3.2.2. 18kDa Promoter 
The 18kDa has a of relatedness to heat shock 
drives of the 18kDa ::.nt·inl',n in M. et 
such as heat shock 
18kDa for use as a 
mv,cot,ad:eri,al shuttle vectors due to its suspected cat:taCilty for 
of gene 
In I4vo. The 18kDa was shown to have weak :;;orr,'H'rv 
10 
", .. ",m,.,,",:,,,,,,, and 
As with other 
the 
in E. coli-
<>y., .. ",,:<::ir,n levels 
of M. 
sm,'!':ar.nat.IS and BeG and to be in In vivo <>y,,,",,,,,c 
levels induced the 18kDa are lower than levels induced under the control of the 
", .. ",m,., .. ", .. in a similar of lower levels In vitro the 
18kDa nrr,mr,hor may see it utilised in £. shuttle vectors of 
recombinant mycot)adterial vaccines. 
1.3.2.3. mtrA Promoter 
Within M. mtrA and mtrB constitute a 
transduction Constitutive under the control of the mtrA is 
for In vitro of M. tuberculosis & 
was of interest to researchers In vivo to better 
understand M. tuberculosis virulence. Studies which introduced the mtrA into BeG 
as a non-virulent control for revealed that the mtrA is inducible In I4vo 
in BeG. Further and Fl51JDL'-UIIJ nlrl'\"""",o .. 
fusions. Constructs in BeG were used to infect m::.rrr,nh::.n&'<: and fluorescence levels were 
monitored flow 
the fluorescence levels were not increased in vivo whereas the mtrA-
'n ... '''''r,.,n/·., levels increased a fluorescent unit to reach levels similar to 
"nllnwlnn m"'r ... nnh'.n<> infection. Relative to the the mtrA 
lower in vitro n",,'IAwh of M. 
the mtrA is a candidate for the n .. I",IYII'1,l'o .. of choice within £. 
coJ'l-mYC()ba,dtE!rial shuttle vectors intended for recombinant vaccines. 
1.3. 3. RECOMBINANT 
To an extensive of recombinant genes has been off £. coli-
mycotlad~erial shuttle vectors for of recombinant vaccines or nl>lrll>tir 











':>'>(''''1'",,,=./1 in efforts to [Jf'>\/f'>lrl[} vaccines. These include viral genes from HIV & 
SIV and measles virus et bacterial 
genes from Str.eptocclCCLIS nne'"lmlmi;;,e Borrelia 
et and Bordetella as well as genes from 
Plasmodium and Leishmania 
D", .. ""rt,,, .. genes have been in numerous recombinant studies. In 
terms of vaccine genes are useful as models for genes and 
can be used in gene fusions for and In the context 




Because GFP is known to be 
was selected as a model 
1.3.3.1. Codon 
genes have been U~III"''''\'', these include the 
et luciferase , .. g''-vu ... Jr. et 
et alkaline 
which codes for MalE 
stable and has been utilised ov1"onC:l"O"J in it 
for use in ov"roc:.,;r.n vectors in this 
recombinant gene levels among similar 
vectors have revealed considerable variation. For "'v~lmnIO the same recombinant 
-oalactosiida:se was ",v,.,,.,,,,<:,,,,,,,,11 at levels 200-fold than HIV-
1 This observation that the reasons for 
""vr, ..... ,:<:;r.n levels exist with the genes themselves. Some recombinant genes were suspec:ted 
to be toxic to Variable gene translation efficiencies were also to affect 
",vr, ...... :<:ir.n levels. Since are G-C have a codon bias for 
residues of similar constitution et As genes with <:,,,,,,,,1""-2 
lower G-C contents may incur a metabolic burden on hosts which would reduce 
Codon genes has therefore been as a 
c::tr;ltI!>l"IV to increase f"nrnnlii::lnl'''' with the mycottad:eri.al codon bias 
cinnifir;;:",tlv c::trr\nn,,,r immune responses to a rBCG vaccine 
than that the 
was due to an increase in recombinant ;;:,nl,n'::'n ""'IInr.",c<:.inn levels as 











1.3.3.2. Secretion Siglnalls 
As \,I,"''-Y;:,;X;,,,,, one of the reasons for recombinant gene "'vr,...,.,~dr'n is the 1'I""~",,.:,.t-jr,n of 
vaccine candidates In terms of vaccine it has been that 
because most recombinant _~"~i •• ~ are located in the their exposure to the 
immune the immune response cn.:>rifir to recombinant ~ntinl'>l'I<: 
may be restricted l"'nn",r.v & Wil,li~rnc:r1n It was that this obstacle may 
be overcome recombinant from vaccine vector. 
1 1"'1.,.,.",1",,...,.1'> the from kansasii was 
to a recombinant gene et This allowed for the combined extracellular 
secretion of the and the recombinant studies fused 
recombinant genes to the 18kDa gene the from M. or the 
19kDa M. tuberculosis to of recombinant to the 
immune et et In fusion of 
recombinant genes to 85A secretion has been utilised to increase levels of recombinant 
gene & 
1.3.4. THE MYCOBACTERIAL REPLICON 
1.3.4.1. Detailed Functional .. "''''''''.''' of the MYjl:olll8d:eri,al Reol'icQin 
The of E shuttle vectors to r"'nlir"'l~o is most 
the DAL.501JO-llenvea my(:ob<actE~nal 
of the entire UI"IL.JU\JU revealed five open frames 
nve:sti<:lathDns were carried out into the CN'r,f'r functions of 
each ORF while the functions of ORFs 3 and 4 remain ORFs 1, 2 and 
5; since named the and rap genes resoel:t:lVelv were revealed to function in 
The appears to have h"I"nnI/Vl\l to the rej:'liG~se group of nrnfl'>lt'l<: and has been 
demonstrated as a for ret:lliG!ticln 
shown to be an essential for relJlliG!tioin 
mycotladterial r~""""T\n rnrnm,nnilv included in E 
both The helix-turn-helix motif of 
of nrntoirlc which bind to DNA 
has also been 
For this reason, the 
col.f-myc()bacterial shuttle vectors includes 
resembles that seen in the structure 
et t":::lIncr,rintinn~1 start 











identification of a 
et This 
n&:>lin::u·n .... sequence 
13 
was the 
and rap contains the oriM. within the C-terminus of 
was shown to bind to two c:n<:l.rifi.~iti~>c: termed and Low 
sites and It has been that the L-site is in fact the 
oriM. The H-site is riddled with ... .0,.,"""' . ..." sequences and nv .. ·rv .. ' .... 
for and which led to that its own &:>V'''',,'':::c:irm 
&. and host factors were shown to stimulate to the ori 
were as a The 
structure of was further shown to be influenced the I.Vl.!.l'<:;U .o'vn .. " .. :",k,n of and 
The rap gene lies in the op~)osi·te orientation to and et The 
it encodes was shown to have an function with 
Studies that was non-essential to It was :::.lh'rn;::.ti\"",lv 
prOI)OSE!O that a host factor to enable repllicaltion 
Since rap was revealed to be rli",..,.,.r,,,,,,h,o for it is truncated in the 
mycotladterial ... "",Ii,-I"\n of £. shuttle vectors. This may be a 
l"lv':'r<:i,nht however as Stolt and Stoker demonstrated that transformed 
with vectors ,;;orru"",., rap formed colonies faster and of copy number 
than those the truncated rap in M. Sme(JInal':is and BCG. The 
authors suglge~;ted that two ""'''''0:::''1'<:: within rap may be for 
increased nl:::.crnirl 
site was identified 
of direct 
which in turn 
downstream of the 
t" ... ""ncr ... int'i .... n!:lll start 
site et This 
suggestea that reD,4-n~Df:i rap may have l"lvt'>rl;l,nn,inn nrr,mr\t",,'c: 
Since and are for their limits the copy number of 
E. shuttle vectors which has been determined to average five per 
cell et £. shuttle vectors of copy 
number are desirable for two main reasons. First to increase the 
extraction and second to recombinant gene &:>vr,r&:>':::c:irln 
The latter is of for recombinant vaccines where Imr',. .... ''''''n 














,/ / L Sit\ 
,~~ site _mycobacterial replicon 
~1 
repA 
Figure 1.1. Annotation of the entire Mycobacterium fortuitum pALSOOO plasmid. 
1.3.4.2. Recent Optimisation of the Mycobacterial Replicon 
The mycobacterial replicon region was originally selected rather primitively, based on the 
position of unique restriction sites and, besides two recent studies which modified the 
mycobacterial replicon to achieve increased copy number, the mycobacterial replicon has 
been little modified since (Stover et at, 1993). Typical E. coif-mycobacterial shuttle vectors 
have been estimated to have a copy number of approximately five (Ranes et at, 1990). A 
higher copy number phenotype is desirable since it increases yields obtained during vector 
isolation. Furthermore, it is logical that as copy number increases, so recombinant gene 
expression increases. Although not always the case, several vaccine studies have shown that 
increased levels of recombinant protein result in an improved immune response. High copy 
number phenotypes have been attained using differing strategies. One employed strategy 
utilised random mutagenesis combined with positive selection to achieve an approximately 
seven-fold increase in copy number in both M. smegmatis and BCG (Bourn et at, 2007). 
Sequencing revealed this phenotype to be the result of an Alanine deletion within the C-
terminus of RepA. It was postulated that the mutation modified RNA folding, which influenced 
repA-repB expression. The second strategy involved overexpression of RepB from the M. 











1.4. RATIONALE FOR STUDY 
recent advances in functional f'I",rlnn'lirc 
has not been altered may be a cif'l,~ifil":::Int n"'>I"'<:I,nl"l1" 
fact that the mY<:ODi:lctEmal .. ",nlirnn 
shuttle vectors 
continue to exhibit low ov,,,-o.,,.,irln 
"'''''TII'_ the mycotladterial r""nli,'V\n 
l'irl'''r,'ion,nl" this aimed to further 
mycotladterial r"'.nli,~nn found in the of E 
coh~ml(Coltlacterial shuttle """'"',,,,"', the was 
selected as the <:t:::lrtirll1 since fin,ion .... " would have the widest relevance. 
This was searched for causes of poor 
elements within the 
• the lack of tr:::ll"l<:rrintinn terminators Tn1lnW1n11 the rap and 
• the low copy number 
and 
were 
The rap gene is TUnlr;;o'l\I truncated in E mY1cotladteri,al shuttle vectors as it encodes an 
factor which is not essential for et As 
it was demonstrated that vectors the full rap grew faster and had 
copy numbers than vectors truncated rap in M. and BeG 
& aimed to evaluate inclusion of the 
entire rap gene over its common truncated form. This modification would be carried out for 
the dual purpose of and copy number. 
As indicated in 
oriE. Th,"r",f:nr", 
the truncated rap gene is nI"l'::itil,nool(1 inrlmledi.:ltelly ,netr.o",,.... of the 
unterminated which may cause t":::Ilncrrint'inn:::ll1 read-its tr:::llln<:rrint'inn is 
into the oriE. In termination of tr:::lln<:r ... inl"inn is TUn"' .... "" a 
codon at the end of a gene and a downstream ""':::Ina'r, 
Where neither a codon nor a terminator is "' .. " .. """ .. " as is the case for truncated 
genes such as rap, is non-terminated and .. "''''1'1_1', ..... ''' into noi.'1hh,n, 
genes occurs et This results in the of extended mRNA 
translation of extended mRNA n"I", .. on"" may lead to the 
of nonsense 
this 
and contribute to metabolic stress and 











downstream of the rap gene to eliminate possible instability caused by transcriptional read-
through into the oriE. 
rrsn terminator 












;"'IIII ........ r""''tirul7cated rap 
repA 
Include entire rap 
gene + its putative 
terminator 
Figure 1.2. Targets for modification of the mycobacterial replicon typical in E. coli-
mycobacterial shuttle vectors. 
Targets include: .. the truncated rap gene and its lack of terminator, + the absence of a 
transcription terminator downstream of the rep8 gene, and + the low plasmid copy number 
At the 3' end of the mycobacterial replicon, the rep8 gene ends upstream of the promoter 
region and RBS for the expressed antigen. The fact that the entire rep8 gene is present 
implies that its translation is likely to be halted by a stop codon. As is the case for the 
truncated rap gene, no terminator appears to be positioned downstream of rep8. As a result, 
transcription of rep8 may be inefficiently terminated and interfere with the promoter region 
and RBS of the expression cassette. Thus, this study aimed to insert an hsp60 mycobacterial 
terminator downstream of rep8 to prevent possible interference with the promoter region and 











As most j./MII....Jl.lfVV··ua:.c:u vectors have a copy number of ;::onr)rn\{im.:=Itl'llv 
nOlNel,er this has been increased seven-fold fnllnwinn a cru:>rifiir Alanine deletion within the 
gene This aimed to the copy number 
mutation in 
isolation. 
for mn,'n""" recombinant gene ov,", .. a,~",ir'n levels and nrl'.;::oh>r ease of vector 
1.5. STUDY AIMS 
In the O[)1IE!C[lves of this were: 
.. To construct a modified .,v, .. ,..,,:dr,n a full 
downstream TarmlF'::>T" .. 
number mutation within 
a terminator downstream of 
rap gene and its 
and a copy 
.. To construct a series of intermediate 
modified vector . 
",vr, .. ",.:.,i",n vectors with which to evaluate the 
.. To transform the modified vector and intermediate I'Ivr)rl'l'::c:i".n vectors into M. 
BeG for evaluation . 
.. To evaluate ",vr,,.,,.,,ci,.,n levels of a model ror,l'\mhi gene in ",vr, .. .,'::"",..,n vectors . 
.. To evaluate copy number of the ",V,\,..",e::ir,n vectors . 











2.1. MODIFICATION OF THE MYCOBACTERIAL REPLICON OF AN E. COLI-
MYCOBACTERIAL SHUTTLE VECTOR 
Plasmid pHIGH100 (obtained from Dr William Bourn) and pRC100 (obtained from Dr 
Rosamund Chapman) functioned as the derivative E coif-mycobacterial shuttle vectors from 
which modified vectors for the study could be generated. The mycobacterial replicon of 
pHIGH100 is characterised by a number of deSirable modifications: the high copy number 
mutation, repA, repB, full length rap and truncated ORF3 and ORF4 (Fig. 2.1). Accordingly 
the pHIGH100 mycobacterial replicon was utilised as the template for bioinformatic searches 
and subsequent PCR. Plasmid pRClOO provided the desired vector backbone which comprised 





Figure 2.1. Structure of the plasmid pHIGH100 
EcoRI (1308) 
truncated ORF4 
2.1.1. BIOINFORMATIC SCANNING OF THE MYCOBACTERIAL REPLICON FOR 
TERMINATORS 
DNA sequence downstream of the rap and repB genes in plasmid pHIGHlOO [GenBank 
Accession No: EF216316] was scanned for putative intrinsic transcription terminators using 











were set to identify terminators with a stem consisting of a minimum of seven paired base 
pairs and a loop consisting of a maximum of 35 unpaired base pairs. 
2.1.2. SEQUENCING OF THE MYCOBACTERIAL REPLICON OF THE PCR TEMPLATE 
As the GenBank pHIGH100 and pAL5000 nucleotide sequences were known to differ from 
that of the pHIGHlOO used in our laboratory (Personal communication from Dr William 
Bourn), the nucleotide sequence of the mycobacterial replicon of plasmid pHIGH100 was 
confirmed prior to amplification. The sequencing strategy is depicted in Figure 2.2. 
SGrap-F 
--.~ ........................................ .. 
SGrepA-F 
--.~ .......... ............................................. .. 
SGrepA-R 
.... ........... ........ ......... ... ............. ............ --
SGrep8-R 
....................................................... --
(fir + II (epA (epB 
Figure 2.2. Strategy for sequencing the mycobacterial replicon of PCR template 
pHIGH100. 
Utilised primers are represented as arrows. The various fragments of sequence produced by 
individual sequencing reactions are indicated by the dotted lines. A consensus sequence was 
generated by the alignment of overlapping sequence files. 
Primers were designed with the aid of Primer Design software package [Freeware, version 1J 
(Table 2.1) and sequencing reactions were prepared using the Big Dye Terminator v3.1 cycle 
sequencing kit [Applied Biosystems]. Cycle sequencing was performed in the GeneAmp® PCR 
System 9700 thermocycler [Applied BiosystemsJ by the Genome Platform of the Department 
of Human Genetics, University of Cape Town. Sequences were edited using the Chromas v2.3 
software package [TechnelysiumJ and aligned with the GenBank pHIGH 100 and pAL5000 
[GenBank Accession No: M23557J sequences using the DNAMAN bioinformatics software 












, SGrap-F Forward Sequendng of PCR Template pHIGHIOO 5' ~ GTT GGA TTC GGA GAC MG C 3' 
PeR Amplification Stage 1 + 3 
Sequencing of PeR Product from Stage 1 
'SGrepA-R Reverse Sequencing of PCR Template pHIGHIOO 5' TCG TTG CAC GGA TCG3' 
PeR Amplification Stage 1 
Sequendng of PeR Product from Stage 1 
, SGrepA-F Forward Sequencing of PeR Template pHIGHI00 5' TTC GAT TCC GTC AGG TTG TG 3' 
PeR Amplification Stage 2 
Sequencing of PeR Product from Stage 2 
Kpnl 
, SGrepB-R Reverse Sequencing of PeR Template pHIGHI00 5' ~ GM ACA TGC GCA ACG MC 3' 
PeR Amplification Stage 2 + 3 
Sequencing of PCR Product from Stage 2 
T7 Forward Sequencing of pSGIOO insert 5' TM TAC GAC TCA CTA TAG GG 3' 
.' Primers were designed with the aid of Primer Design SOftware Package [freeware, Version 1. J and synthesised at the DNA Synthesis Service, 
Department of Molecular and Cell Biology, University of Cape Town 
Restriction enzyme sites introduced for subsequent cloning are underlined 
Additional nucleotide Introduced to disrupt £CoRl restriction site is in parentheses 
2.1.3, PCR AMPLIFICATION OF THE MYCOBACTERIAL REPLICON CONTAINING 
FULL LENGTH RAP AND THE HIGH COPY NUMBER MUTATION 
A tnree-st<lloe PeR c:+ .. :.t.,rnl was ol'Tln.n'"on to :::om,nlll"\1 the copy number my,cot)ad:enal 
it for ;:'UI.J;>C:\.IUCI PeR 
PCR 2400 was carried out 
The various utilised for PeR are tabulated in Table 2.1. 
2.1.3.1. One 
A 1.372 kb rap, a rap terminator and a of was 
from of DNA was used as 
tpnnnl:::Itp in a final reaction volume of and 
0.2mM of the four de()xv-nuclec)tidles, 0.125U Pfu DNA 
1x Pfu reaction buffer of 4mM and DMSO. PCR conditions 
consisted of an initial for 3 minutes followed of 
denaturation at for 30 at 
for 2 minutes and 50 seconds Inl"',..,,, .. ::II'1.fl 5 seconds per and a 7 minute 











introduced an MluI site downstream of the rap terminator. The reverse 
R introduced an nucleotide within the EcoRI site to it. This was 
done to preserve the of a seoond EcoRI at the 3' end of the 
of the to enable future of 
n ... ",m",.!'o ... elements in our I",hn ... ~,tn, .. , Three nor''''!'I\''''' controls were n"""t'I.OII\I a 
!":"'nnl:"l'o.It ... ~."" contamination control and two nn".c, .. .,..,ifir 





2.1.3.2. Amplifica1t1on Two 
the 
of 
two a 1.171 kb It",:>,nm",nl' was ::omnlifl<>rl from which '''I<>I'I::onn<>I"I with 
::omnlif'iorl in one 150 The PCR 
copy number the entire gene and some 
sequence downstream of Conditions were consistent with those outlined for one 
that and were used and time was decreased to 
2 minutes and 20 seconds. To assist in later a site was introduced the 
reverse one, a oontamination oontrol and two 
controls were included. PCR size was confirmed 
the PeR ::omnlifir:>'"inn 
2.1.2. for 
2.1.3.3. AmlDunaltlClln Three 
The final modified three was rh::o,r:>rt",ri 
the copy number the full and rap genes( the rap 
terminator and restriction sites. Aside from the noted 
conditions were oonsistent with those outlined for one. A mixture of 
of each one and two served as Forward and 
reverse were used. time was increased to 4 minutes. While a 
oontamination oontrol was oontrols were unnecessary since 
Te""'"'"'T''''' and three had been tested either in one 
or two. Because ooncentrations of from one and two were used as 











Stage 1 ML 
... ..... ~ 
SGrap-F SGrepA-R 









•• . ..... ~ I 
Stage 2 SGrepA-F SGrepB-R 





I • HI 2409 
EcoRI 
Stage 3 Mlul 
I rap + It SGrepB-R .. ........ ... .. .... ...... ............. .. ....... ... .. .. ~ 
Kpn I 




Mlu I Kpn I Mlu I Kpnl 
f Ap ~ It (epA (epB I faD + It repA (epB I 
I 
HI 2409 HI 2409 
£CoRl 











from the one PCR nm,orc,o,\I the second half of the contained an intact 
EcoRI site since the 
size was confirmed 
the ::Im,nlif'lIPI1 fr::l.nm,pnt was 
two acted as its The PCR 
was not carried out at this as 
2.1.4. CONSTRUcnON OF THE MODIFIED E. COLI-MYCOBACTERIAL SHUTTLE 
VECTOR 
General recombinant used in are outlined here. Vectors and DNA 
t'I"::I/,m".nT'<:: were restriction enzymes as per 
instruction. sizes were determined resolution on a 
1 % agarose either a 1 kb marker 
diglestE~ with Pst!. Desired were from agarose Gel 
Extraction Kit or from reaction mixes Purification Kit 
cells 
et al 
to the ::>U1-'i-'lIt:u nlcnt"lrI"Il 
from the BioVac were made rnrnn.>tIPI~t 
In""tll~r\<:: were transformed into mln ...... 1-"" .. !" 
for 
transformants were selected transformed cells onto 25ml of 2YT 
NaCI per litre of solid medium with 
n::lnnvron and at 37 Selected colonies were used to inoculate 1ml of 2YT 
.nnl ..... ''''nt'''l1 with and incubated at 370C with 
for aeration. Small amounts of DNA were isolated from initial 
transformants with a resistant nho,nn!"\lnQ the alkaline method of Ish-
Horowicz and Burke and used to conduct e .. r,nl"llil",,..,, c:rr,ppn,inn restriction 
The Nudeobond /lJ( PC-Kit was used to the ::>U1J'i-'lIt:u 
nrr;,r,."..r.' to isolate 
tra nsforma nts. 
amounts of n ...... """<1 DNA from 100ml cultures of confirmed nne:',I\,'''' 
2.1.4.1. Construction of SUb-Clone 
An EcoRI was no",tn .. ",,011 to isolate the EcoRHree half of the 2.409 kb final PCR 
from three. The EcoRHree PCR was The 
resultant isolated T'r::l,nm",nT' therefore consisted of a mycot)adte r"'niljr .. 1n modified to lack 










mutation and the 
modified mY4:oblactE~rial 
and doned into the 
insert to vector ratio 





genes. To sub-clone this 
was A-tailed 
I] at a 1: 1 
the manufacturer. Transformation 
with O.5mM IPTG and 
The identification of desired transformants as white colonies was 
facilitated selection for laOtoslaa~;e insertional inactivation and alT"nlr'lII resistance 
A SaIl was used to confirm insertion of the 
in the correct orientation. The insert in the 
sub-clone was the modified vector oS(33(JIO before its use in 
and universal SP6 and 17 section 2.1.2. for 
2.1.4.2. Construction of Sub-Clone .., .... "' ...... .., 
Sub-clone p5(32CIO was ",,,,, .. "'~:>t-"'.rI to introduce a t-r:>n.,,"ri terminator t-nllnu,inl"f the 
gene within the my,cottaOterial rc • .-.Ii."" ... luclleoltidE~S were to create a M. bovis 
tr;!ln<:r1rint'inn terminator similar in sequence to that 
luclleo1tidE~ were n"":IlUl<"rl to 
nh(~"nhn'"\/I",t",rl 5' ends to assist In ",rlfliti,.,n 
and Xbal 
an internal XhoI site 
was inr,n~nn .. ",t",,", to allow confirmation of the presence of the terminator via restriction 
were annealed 
luclleoltidE~S in STE Buffer 
The reaction mix was heated to 9SoC and allowed to cool 
of structure. To the 
t .. ""nc:rrint'inn terminator were 
concentrations of 
1mM 
to nrl"'VP'"lT the formation 
at as: 1 insert to vector ratio to 
the backbone of vector U"'_.l.\J'V which was isolated tnlll'\\Al,nl"f 
The vector backbone contained a gene on,'nrlinn a resistance gene, 
an oriE and an unmodified myco[)aocenal ,..""t",;nir,,., a truncated rap gene, the 
gene, the gene and the copy number mutation ........ '-,\..'-'~..." insertion of the 











S'-CGAGGAGCCCGGTCCCTTI GTGG GGCCGGGCTCCTCCTCGAGT -3' 
1111111111111111111111111111111111111111111 
3'-CATGGCTCCTCGGGCCAGGGAAACACCCCGGCCCGAGGAGGAGCTCAGATC-S' 
KpnI XhoI Xba I 
Figure 2.4. Annealed oligonucleotides with overhangs. 
Restriction sites KpnI, Xhol and Xbal are highlighted. 
2.1.4.3. Construction of Modified Vector pSG300 
The E.colf-mycobacterial shuttle vector, pSG300, was generated to contain the fully modified 
mycobacterial replicon. The optimised mycobacterial replicon consisted of the high copy 
number mutation, the entire rap gene, its putative terminator, the complete repA and repB 
genes and an hsp60 transcription terminator following the repB gene. A KpnI Mlulsequential 
digest of pSG100 preceded isolation of the modified mycobacterial replicon fragment 
consisting of the high copy number mutation and full length rap. A KpnI Mlul sequential 
digest of pSG200 was used to isolate the vector backbone containing the hsp60 transcription 
-
terminator. The modified mycobacterial replicon was ligated at a 1: 1 insert to vector ratio to 
the modified backbone at the KpnI and Mlul restriction sites to create the vector pSG300. 
This optimised expression vector was mapped using the Xholrestriction site. 
2.2. CONSTRUCTION OF INTERMEDIATE E. COLI-MYCOBACTERIAL SHUTTLE 
VECTORS 
Three intermediate E. calf-mycobacterial shuttle vectors were constructed for use in specific 
evaluation of each of the modifications made to the mycobacterial replicon in the optimised E. 
calf-mycobacterial shuttle vector. 
2.2.1. CONSTRUCTION OF INTERMEDIATE VECTOR pSG400 
Intermediate vector pSG400 was constructed to evaluate the effects of incorporating the high 
copy number mutation into the mycobacterial replicon. This could be determined by directly 
comparing pSG400, which had the high copy number mutation, to unmodified vector pRC100 
which lacked the mutation but was otherwise identical. To construct pSG400, a high copy 
number fragment containing repA, repB and truncated rap, was obtained following a 











below) with Kpnl and Mlul A backbone fragment containing the hsp60 promoter, GFP, the 
kanamycin resistance gene and oriE was isolated from similarly digested pRC100. The two 
fragments were ligated at a 3: 1 insert to vector ratio to produce intermediate construct 
pSG400. Restriction enzyme mapping with Kpnl and Mlul was performed to confirm the 
conservation of sites and additional confirmatory restriction analyses were carried out using 
Sail and 8gl11 
2.2.2. CONSTRUCTION OF INTERMEDIATE VECTOR pSG500 
Intermediate vector pSGSOO was constructed to determine the effect of including the full 
length rap gene in the mycobacterial replicon. Since pSGSOO differed from pSG400 in that it 
contained the entire rap gene, but was otherwise identical, the effect of inclusion of the full 
rap could be determined by directly comparing the vectors. Vector pSGSOO was constructed 
using optimised vector pSG300 and unmodified vector pRClOO. Following a sequential digest 
of pSG300 with Kpnl and MluI, the high copy number fragment containing full length rap, 
repA and rep8 was obtained. A fragment containing kanamycin resistance and oriE was gel 
purified from similarly digested pRC100. The two fragments were ligated at a 3:1 insert to 
vector ratio to yield intermediate construct pSGSOO. Restriction enzyme mapping using Kpnl 
and Mlul was performed to confirm the conservation of sites and a further Sail restriction 
analysis was carried out to confirm plasmid structure. 
2.2.3. CONSTRUCTION OF INTERMEDIATE VECTOR pSG600 
Intermediate vector pSG600 was generated for the purpose of evaluating the effect of 
introducing the hsp60 terminator following rep8 within the mycobacterial replicon. Plasmid 
pSG600 differed from pSG400 in that it contained the hsp60 terminator but was otherwise 
identical. Therefore, these vectors could be directly compared to appraise the effect of 
including the hsp60 terminator. Vector pSG600 was created from modified vector pSG300 and 
unmodified vector pRClOO. Following a sequential digest of pSG300 with 8gl11 and HpaI, a 
fragment containing repA and the high copy number mutation, rep8, the hsp60 terminator, 
the hsp60 promoter and GFP was isolated. A fragment containing kanamycin resistance, oriE 
and truncated rap was gel purified from similarly digested pRClOO. The two fragments were 
ligated at a 3: 1 insert to vector ratio to yield intermediate construct pSG600. Restriction 
enzyme mapping using 8gl11 and Hpal was used to confirm conservation of restriction sites 











2.3. TRANSFORMATION OF E. COLI-MYCOBACTERIAL SHUTTLE VECTORS INTO 
MYCOBACTERIA 
Modified vector and intermediate 
and were transformed into M. the 
BioVac and M. boy's BCG Pasteur from Dr 
William Jacobs cells cells 
were Parish and 
with DNA Gene 
Puiser™ at and 1000.0. In order to obtain 
cells were onto 35ml of Middlebrook 7HIO solid medium 
with oleic-acid albumin dextrose and 
Plates were from 
and ;::'U,-,';::o<;;;\,IU<:::' incubated at 370 C for two to three sm,eQlnal7s or three to four 
weeks for BCG formation. Colonies were used to inoculate Middlebrook 
medium t:>m.:>nb>l1 with OADC and ,,,mPOlnl'lf'l,, and BCG 
LU""" , .... ,'"" cultures were further , ........ It:>"'."'ntM with tween80 or 
to reduce cell BCG cultures were 
with and Cultures 
were incubated at 370 C with in order to minimise cell 
of 0.4-1.0 was reached. For M. smealnat1s this took one to two and 
Pure for BCG 10 to 25 
Plasmid Isolation Kit 
Plasmid DNA was isolated from transformants 
to the method described 
the 
Parish and 
Stoker Because my,cotlad:eri,al nli;:tc:rnil1 is 
DNA was used to transform E. co/ifor "'u .. '''''''''~u<;;, verification. Recombinant n,,,,'=rn,,,,,, isolated 
m"' .... n~.r1 with restriction enzymes to confirm their n"'n",,..,., structure. from E. coli were 
In ",r1 ... liti",n a XbaI restriction was carried out c:n~"ifiir;:tllv to confirm 











2.4. EVALUATION OF THE MODIFIED E. COLI-MYCOBACTERIAL SHUTTLE VECTOR 
2.4.1. EVALUATION OF GFP EXPRESSION LEVELS 
2.4.1.1. GFP Fluorescence 
Relative levels of GFP fluoresoence were estimated for recombinant M. smegr.na1.7S 
BCG Colonies were viewed and on a Chromato-vue TM-20 
Transilluminator at 254nm to visualise GFP f1uorescenoe as a 
indication of GFP pvr\rp'::cll'.n levels. 
2.4.1.2. GFP Western Blot An,::;I"!I:!!!: 
Relative levels of GFP 
recombinant M. smealnalts 
were determined via Western blots for 
mycot>adterial cultures were harvested 
10 the Pellets were washed in 10ml 
as before. Cells were esulsp€:ndE~d in 
1ml PBS and transferred to FastRNA tubes O.lmm zirconia-silica beads 
[Bi()Spec]. Cell were four 30 second of 
at 6. Tubes were cooled on ice between .. ",n,::o",h:: 
in the I"n ... "nrlnM' 5415R 10 
was collected and stored in at -Sooc. Protein concentration of all was 
determined the Oc BioRad ,;:,nirit;:,irinn Kit to instruction. 
Protein shown in Table 2.2. were """"''''I'"",t",rI 50S-PAGE on 12.5% 
::Ilnnn<:it1p Kalleld()sc()pe Molecular Marker Gels 
were run in tri~)licc~te. 
identical 50S-PAGE 
used to transfer 
was demonstrated one of the three 
A TransBlot c<>n,,-t'l,n.1 transfer oell 
40 from the two 50S-PAGE 
was 
onto 
nitrooellulose membrane. M mbranes were in block buffer (1 and 
then with a mouse monoclonal anti-GFP nrIlTl;:!''V " .. ,t-Ihrvl" diluted 1:1000 in 
block buffer (1 Blots were washed three times in wash buffer 
after which were with anti-rabbit alkaline nh ... ,cnl",;:,t::>""" 











blots were ne1Jell)nF'n Nitro blue tetrazolium 5-bromo-4-chloro-3-
Positive Control rH. smegmatisor rBCG I'1panCDpHS207* High GFP-expresser Cell lysate 
Positive Control + MW Standard rE. coli expressing GFP GFP protein Purified protein 
Negative Control rH. smegmatisor rBCG I'1panCDpHS200* Non GFP-expresser Cell lysate 
Experimental rH. smegmafisor rBCG I'1panCDpRC100 Unknown Cell lysate 
Experimental r M. smegmafis or rBCG I'1panCD pSG300 Unknown Cell lysate 
Experimental r H. smegmatis or rBCG I'1panCD pSG400 Unknown Cell lysate 
Experimental r H. smegmafis or rBCG I'1panCD pSG500 Unknown Cell lysate 
MW- Molecular Weight 
'Plasmlds pHS207 and pHS200 were obtained from Or Helen Stulz 
2.4.1.3. GFP Cal,tUl'e ELISA 
GFP t:>vr)Ft:><~<::i('\n levels for recombinant M. .t;mea/nalit; BeG '''-''7I1LI1 were 
GFP ELISA n.:>ITnr'ml=lI1 in .... i .... Ii,.."·t'" 
Cell was isolated and its content l::In!tit::ltM as in 2.4.1.2. Protein <::::Innnl,><:: 
used and their functions are outlined in Table 2.3. For purposes, 
recombinant GFP was used to a linear standard curve. 
were diluted in PBST 1 % milk and incubated in wells of 
96-well with anti-GFP (1 
Wells were washed four times with PBST 





Peroxidase Substrate in 
manufacturer's nrnrnrnl to detect the HRP. The detection reaction was stoDDE~ 
per well. Absorbandes were read in a PR2100 ELISA 




from the standard curve and corrected the dilution factor to determine the of 
GFP Statistica 7 Software was used to 

















Positive Control rM. smegmatisor rBCG apanCDpHS207* 
Positive Control + MW Standard rE. coIiexpresslng GFP 
Negative Control rM. smegmatisor rBCG apanCDpHS200* 
Experimental rM. smegmatfsor rBCG apanCDpRCI00 
Experimental rM. smegmatlsor rBCG apanCDpSG300 
Experimental rM. smegmatfsor rBCG apanCDpSG400 
Experimental rM. smegmatlsor rBCG apanCDpSGSOO 
MW- Molecular Weight 
*Plasmids pHS207 and pHS200 were obtained from Dr Helen Stutz 
2.4.2. EVALUATION OF VECTOR COPY NUMBER 
2.4.2.1. Restriction Diolest AnaIV'SIS 
31 
High GFP-expresser Cell lysate 
GFP protein Purified protein 
Non GFP-expresser Cell lysate 
Unknown Cell lysate 
Unknown Cell lysate 
Unknown Cell lysate 
Unknown Cell lysate 
To determine relative differences in nB,",'o;;rnlln copy recombinant M .. <:""POm;;,ti<: and 
BCG /\l""IILLI total DNA was to compare to chromosomal 
intensities. 
Total DNA was extracted from 100ml c::t::llrinni::lN cultures of recombinant M. sm,egt:nal7S 
and BeG Harvested cultures were washed in 20ml MTB extraction buffer 
monosodium 
extraction buffer 
50mM and incubated in 12ml of MTB 
I'J"''''''''Jm<> rV'nAlt'le>r for 5-6 hours at 37"C. 
were incubated for a further 14-18 hours at 45"C I'nlln"",nn the addition of RNase 
50mM 
nrr,tl"in::l<:'<> K buffer 
was extracted with an volume of 
and total DNA nr"'riM.it::l·~",rI in the aqueous 
addition of 0.7 volume lc::nr\rnr\::In,nl of 5M Sodium Acetate. PrecipitatE!d total 
DNA was esu!spe~ndE~d in 1 ml TE buffer and extracted a 
were second time with an 
washed twice with an volume of chloroform and total DNA nr".,.i.."it",;rori in the aqueous 
addition of 0.7 volume ,,,nY'my,,,,n,nl and of SM Sodium Acetate. Total DNA was 
washed with 0.7 volume of 70% ethanol and TE buffer. Total DNA 











I-1g of total DNA from each was sut:ljected to a double MluI XbaI restriction 
Two-fold dilutions were ... ,.." ... :>," .. ,; in TE buffer. A similar restriction was carried 
out for of DNA. The DNA and two-fold 
dilutions of total DNA were "'<> ... "" .. "'TO>" on 1 % agarose 
the stained in a 0.05% ethidium bromide 
solution. """,,.~·n., GeneTools 
was used to estimate nl:::acrnil'l 
intensities. 
2.4.2.2. OUiillitath,e Real-Time peR 
Software P.:::.r·k'.:::." .. version 
intensities relative to rh",I'\rn,r\cnrn:>1 
real-time PeR was used to determine relative copy numbers in 
recombinant M. and BCG with 165 chromosome- and GFP 
A 5'-VIC labelled TAMRA and 1'1"",l.-il'1'" to the 165 gene in M. 
tuberculosis were available for use from Dr Mark To ensure that this 
set for M. tuberaJlosis would be able to "' ....... ,,"'\r the 165 genes of M. 
smeat:nar.rs and and n,.in~"' .. o:: were tested the online in silica simulation of 
PeR tool The 0::""".1"11'" .... ,1'>1 of the set for the 
165 chromosomal genes in M. smearnatis and BCG was verified sequence hnrnnll""" 
searches the NCBI BLAST The Primer software 
was of a 5'-FAM labelled TAMRA 
and nrin,,,,,.c c....,,~ifir to the GFP gene in nl::.,::rn;.;" U''' ..... JlUU and 05(;300-6100. The 
DNAMAN bioinformatics software oac:kaCle version was used to 
determine the of cross soE'clti,cltv 
reactions had a final volume of and included 1x All real-time PeR .:::.mnlll',r.:::.I', 
Universal PeR Master Mix in various N"Ir"hir,:>ti,r\nc 
of each 165 and of each GFP 
conditions were as follows: an incubation 
of 165 
Mix activation at of a 
denaturation at for 15 seconds and a combined :>n, ... ",,,,iin/,_,,,·,,t,,,,nci, ... n 
for 1 minute. PCR was carried out the ABI Prism 7000 











dilutions of M. sm,eglnalls chromosomal DNA lln:t:: .. r>OI'I from Dr Karen were used as 
",' •• ,n, .... '· to a 165 standard curve of threshold versus the of the amount of 
chromosomal DNA. ten-fold dilutions of DNA were to 
establish the linear range for .:>m,nlifir:;:rl';nn of the GFP gene. T .. , ..... nl.:>til>_f .. """ controls as well as 
crclss-,sOl~ciflcitv controls were included. of recombinant M. 
,<;m,ear:n!'lfi[<; and BeG total DNA 2.4.2.1. for extraction ........ ~,;. .. ,,>J were used as 
' .... ,.,1-1',." real-time peR ng,."fnr"ml!>t1 in 
165 and the ",::..,mln nrr,n",_nr,rn<"" sets. Results were "n:.,,,'=n 
both the chromosomal 
the ABI Prism 7000 
SDS software Version Baseline was set at a level 
than The difference in threshold between the 165 threshold 
and the GFP Ct was used to determine the fold difference in copy number 
for each recombinant relative to the unmodified 
2.4.3.2. !IiiOl'ahili'N 
Recombinant M. and BeG cultures were grown in the absence of 
antibiotic selection for 43 n""1i1> .. .:>t;"nc: to assess in terms of GFP fluorescence and 
antibiotic resistance retention. 
Recombinant BeG cultures were grown in in the absence of antibiotic 
selection. At an of I, cultures were sub-cultured. At each sub-culture 
time was recorded and stocks were stored at -20°C. Based on the 











::::.rr'nrl1iinl"l to the Generation In lin 2 
At each subculture time Ziehl-Neelsen was carried out on 
.."",r", .. ,,," stocks to that cultures were not contaminated 
htvn:mnt stocks were used to cultures onto media with and without selection. 
Colonies were viewed on a Chromato-vue TM-20 Transilluminator at 254nm 
to ascertain the of units which maintained GFP fluorescence. 
with and without selection were used to calculate the 
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3.1. MODIFICATION OF THE MYCOBACTERIAL REPLICON OF AN E. COLI-
MYCOBACTERIAL SHUTTLE VECTOR 
36 
The utilised in £, coli-
mycotladterial shuttle vectors was modified in an to vector and 
increase recombinant levels. The modifications included : 
• of the entire rap genet truncated in £, my<:oO<:lctE!nal shuttle 
to determine the effect on vector staDIII1-;V 
pVf)rp'::C::i(,ln levels 
copy number and recombinant 
• Introduction of a copy number mutation in an to increase recombinant .::.ntll'l",n 
,''''fl • .,.,,,I,,.n levels 
• Indusion of a "!"::II""r"'nf',nn terminator downstream of rap to determine whether vector 
into the oriE 
• Indusion of a ""r'nl"",,, terminator downstream of to establish if vector 
may be .""'F.-U/a,., into the 
Inc::t'I"P:::Im of the recombinant ::lI"!-'no .... 0".,,.0'""''''', cassette. 
In this ",ni.:nml::.l £, my(:0b<3ctE!rial shuttle vectors and 1J"'~.l.\J'V were 
selected as the derivative from which to vectors. 
While both vectors' are based on was utilised as 
the for bioinformatic searches and peR because it contained many of 
the elements desired within the modified the copy 
number mutation and the full rap gene Plasmid "''''_.L,,'Y n'·n\II'''...., 
",vr,,,,,,',c:irln vectors with a backbone which contained the model GFP recombinant a 
nannvr.n resistance gene, and an oriE. 
3.1.1. BIOINFORMATIC SCANNING OF THE MYCOBACTERIAL REPLICON FOR 
TERMINATORS 
The mycotladterial """nlllonn within further differs from the mYCO[laOCenal "~'nli,-nn 
mrrlnnlV found in £, shuttle vectors in that it contains the downstream 
.... fl.nn", of the rap and these in were 
bioinformatics to intrinsic terminators for rap and The 
search tool of the DNAMAN bioinformatics software oaC:Ka<le 











length of seven paired base pairs and a maximum loop of 35 unpaired base pairs. These 
parameters were relatively lenient, considering that a stem length containing a minimum of 
12 bp had been defined previously to identify terminators in prokaryotes bioinformatically 
(Petrillo et a" 2006). 
3.1.1.1. Identification of a Putative rap Gene Transcription Terminator 
A putative transcription terminator was identified 69 bp after the rap gene stop codon in 
pHIGH100 (Figure 3.1). The terminator has a poly-U tailed stem-loop structure. This 













rap-~ ... C - G CCUCGCCCUUUUU 
Figure 3.1. Putative poly-U tailed transcription terminator identified for rap. 
Arrow indicates direction of rap transcription, UGA likely stop codon is boxed and ellipses 
represent 69 bp. 
3.1.1.2. Absence of a repBTerminator 
No homology to intrinsic terminator sequences was identified in the region following the rep8 
gene. Consequently, the M. bovis hsp60 terminator was introduced directly upstream of the 
hsp60 promoter, to prevent transcriptional read-through into the promoter of the expression 
cassette. Approximately 466bp of DNA downstream of the rep8 gene was included as this 
region contains numerous direct and inverted repeats that could play a role in plasmid 











3.1.2. SEQUENCING OF THE MYCOBACTERIAL REPLICON OF THE PCR TEMPLATE 
The mycobacterial replicon of plasmid pHIGH100 served as the template for PCR amplification 
for construction of the modified mycobacterial replicon. Prior to amplification, the nucleotide 
sequence of the pHIGH 100 mycobacterial replicon was confirmed since the GenBank 
pHIGH100 and pAL5000 nucleotide sequences were known to differ from that of the 
pHIGH 100 used in our laboratory (Personal communication from Dr William Bourn). 
3.1.2.1. Identification of an Inconsistency Between Template and Published 
pAL5000 Mycobacterial Replicon Sequence 
Sequencing of the mycobacterial replicon of the pHIGH100 PCR template revealed an 
inconsistency with the GenBank pALSOOO mycobacterial replicon sequence. Within repA, there 
exists a triple direct repeat in the GenBank pALSOOO sequence. One of these 12 bp repeats 
appeared deleted in the pHIGH100 template such that only a single direct repeat remained 




pHIGH100 template sequence 
AGig::jAC:G(~I:& •••••• ~~GQ!M,CGiG<;~d pALSOOO GenBank sequence 
Figure 3.2. Deletion in repA of the pHIGH100 template. 
An alignment of the triple direct repeat is shown; grey shading indicates 100% sequence 
homology, blue shading indicates the sequence of the deleted repeat; ellipses represent the 











3.1.3. PCR AMPLIFICATION OF THE MYCOBACTERIAL REPLICON CONTAINING 
FULL RAP AND THE HIGH COpy NUMBER MUTATION 
Plasmid 100 contained three of the modifications within the final modified 
the copy number the full rap gene and the 
rap terminator. the presence of a second EcoRI site within of the 
100 my,cot)adterial r"" .. U'-.... n was undesirable since vectors in our l"'n' ... r"'!· .... 1"V a 
cassette at the 3' end of the 1"1"",,.,.,,,.1'0.- of the ovrwo.=", 
which allows nl'l',ml'.t",,. elements to be a mn:!e-!;tacle PeR d",.:.t"",V 
in order to isolate the modified 
introduce restriction sites to facilitate ;:'UI...:>t::I..IUC! 
the of the EcoRI site of the nn"',mr.t", .. 
For all three PeR 
two forward 
control reactions did not peR 
two forward 
from the desired of 1.171 kb. In adcllticln 
the peR reaction r .... n'l":::I1I111nl"l 





from the PeR 
was absent from 
confirmed error-free 
3.1.4. CONSTRUCTION OF AN E. COLI-MYCOBACTERIAL SHUTTLE VECTOR 
CONTAINING THE MODIFIED MYCOBACTERIAL REPLICON 
The modified vector was constructed to contain a 
characterised the full rap gene and its 
copy number t .. ""nerrinl·i .... n terminator downstream of The 
outlined in was based on 
the construction of two sutl-Cic:mes: 1,J,;;>UJlVV and pS(;200. A series of restriction enzyme 
confirmed successful of sub-clones and and modified 
"'vr"I'",.:cir'nvectorlJ~'~J~'V 
3.1.4.1. Construction of Sub-Clone 11" ... ' .......... '" 
The EcoRHree 2.409 kb peR 
of the modified vector was cloned into 
The desired half of the PeR three 
for construction 
to construct sub-clone .... "", ..... "" .. 














kb: 23456 2 3 456 
0.0 
75 
c kb: 1 2 3 4 5 6 7 8 9 10 
2.409kb 
Figure 3.3. PCR Amplification of the Mycobacterial Replicon. 
A. PCR Stage one. Amplification of a 1.372 kb portion from the mycobacterial replicon of 
pHIGH100 containing part of repA, the entire rap gene and the putative rap terminator. To 
assist in future cloning, primer SGrap-F introduced a flanking MluIrestriction site downstream 
of the likely rap terminator, and primer SGrepA-R introduced an arbitrary nucleotide within 
the EcoRI site of repA to disrupt it. Lane 1- ADNA/ PstI molecular weight marker, Lane 2-
1.372 kb product, Lane 3- No template control, Lane 4- Forward primer only specificity 
control, Lane 5- Reverse primer only specificity control, Lane 6- Promega 1 kb molecular 
weight marker. B. PCR Stage two. Primers SGrepA-F and SGr pB-R were used to amplify a 
1.171 kb portion from the mycobacterial replicon of pHIGHlOO which overlapped with the 
peR product amplified in stage one by 150 bp and included the high copy number mutation 
within repA, repB and some downstream sequence of repB. To facilitate future cloning, 
SGrepB-R introduced a flanking KpnI restriction site downstream of repB. Lane 1- ADNN Pst! 
molecular weight marker, Lane 2- 1.171 kb product, Lane 3- No template control, Lane 4-
Forward primer only specificity control, Lane 5- Reverse primer only specificity control, Lane 
6- Promega 1kb molecular weight marker. C. PCR Stage three. Equal concentrations of 
product from stage one and two served as template for primers SGrap-F and SGrepB-R to 
amplify the final 2.409 kb modified mycobacterial replicon, characterised by full length rap 
and its putative terminator, repA, the high copy number mutation, repB, some sequence 
downstream of repB and flanking restriction sites with half of the yield containing the intact 
EcoRI site and the other half containing the disrupted EcoRI site. Lane 1- ADNA/ PstI 
molecular weight marker, Lane 2-10- 2.409 kb final mycobacterial replicon product, Lane 10-
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Figure 3.5. Restriction maps of sub-clones, intermediate E. coli-mycobacterial 











site was successfully isolated from the mixed population by an EcoRI restriction digest (Fig. 
3.6). Sequencing of the mycobacterial replicon insert in pGEM-T Easy confirmed the presence 
of the modifications in sub-clone pSG100; namely the high copy number mutation, the entire 
rap gene, a putative rap terminator and a disrupted EcoRI site. 
3.1.4.2. Construction of Sub-Clone pSG200 
Sub-clone pSG200 was generated to provide both the vector backbone and the hsp60 
terminator downstream of rep8 for construction of the modified vector. Oligonucleotides with 
sequence homology to the M. bovis hsp60 terminator were cloned downstream of the rep8 
gene in unmodified expression vector pRClOO to generate pSG200 with a vector backbone 
consisting of the kanamycin resistance gene, the oriE, the gfp gene and the rrsn terminator 
(Fig. 3.4). 
3.1.4.3. Construction of Modified Vector pSG300 
The final modified vector pSG300 was constructed by ligation of the pSG100 modified 
mycobacterial replicon to the hsp60 terminator and vector backbone of pSG200 (Fig. 3.4). 
Modified vector pSG300 thus contained a mycobacterial replicon with all of the desired 
modifications; the full length rap gene and its putative terminator, the high copy number 
mutation within repA, and the hsp60 terminator downstream of rep8. 
3.2. CONSTRUCTION OF INTERMEDIATE £ COLI-MYCOBACTERIAL SHUTTLE 
VECTORS 
To evaluate the collective contribution of the various modifications made to the mycobacterial 
replicon, fully modified expression vector pSG300 could have been directly compared to 
pRC100, harbouring an unmodified mycobacterial replicon. However, in order for any 
observed difference in vector stability, copy number or recombinant antigen expression level 
to be accurately attributed to a specific modification, a series of intermediate expression 
vectors were required which differed from pSG300 by one or more modification. Three 
intermediate expression vectors pSG400, pSGSOO, and pSG600 were constructed for this 
purpose. The various modifications included in each vector are tabulated in Table 3.2. Cloning 
strategies are outlined in Figure 3.7, 3.8, and 3.9. respectively. Restriction enzyme digests 
confirmed successful generation of intermediate expression vectors pSG400, pSGSOO and 
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Figure 3.6. EcoRIdigest of the final stage three PCR yield. 
The desired half of the peR stage three yield containing the disrupted EcoRI restriction site 
was isolated from the mixed population of 2.409 kb products by an EcoRI restriction digest. 
The half of the peR products containing the intact site was digested to yield two fragments of 
1.053 kb and 1.355 kb while the 2.409 kb fragment remained undigested and was therefore 
easily gel purified. Lane 1- ADI\JA/ Pst! molecular weight marker, Lane 2- EcoRI digested peR 
products from stage three. Arrows indicate digested fragment sizes. 
Table 3.2. Differences between mycobacterial replicons of vectors used in evaluating modified 
expression vector 
Vector High copy number mutation Full length rap gene 
pRClOO X x 
pSG400 .,j x 
pSGSOO .,j .,j 
pSG600 .,j x 
pSG300 .,j .,j 
Final modified E. coif mycobacterial shuttle vector is shown in boldface 






3.3. TRANSFORMATION OF E. COLI-MYCOBACTERIAL SHUTTLE VECTORS INTO 
MYCOBACTERIA 
Since this study forms part of a larger initiative to develop mycobacterial-based vaccines for 
Southern Africa, mycobacterial strains were selected accordingly. BeG Pasteur tJpanCD is a 
pantothenic acid-deficient mutant. This particular strain of BeG was utilised in the present 











pantothenic acid. Since the availability of pantothenic acid is very limited within the 
phagosome environment, the growth of this strain is expected to be severely impaired, and 
hence represent a safer candidate vaccine strain for use in immunocompromised individuals 
(Sambandamurthy et al, 2002). M. smegmatis mc2155 is an efficient plasmid transformation 
mutant which has been used extensively in mycobacterial studies. The strain was chosen for 
use in this study as it displays a comparable growth rate to wild-type M. smegmatis and, in 
addition, is currently being pursued as a live bacterial vaccine vector. 
The modified and intermediate E. coif-mycobacterial shuttle vectors were successfully 
transformed into M. smegmatis and BeG 6panCD to allow evaluation of recombinant 
mycobacteria in terms of vector stability, copy number and recombinant antigen expression 
levels. Restriction enzyme digests verified both general plasmid structure and the specific GFP 













I Kpnl Mlul digested + ligated 
RBS 0 
hsp60 Pr , I 
8glll / ' 
Kpnl 
Sail 

















...... ____ ~~ Mlul 
47 










lilp ~ /( 





















Hpa I Xhol 
/ 
BgIII Xhol 












3.4. EVALUATION OF THE MODIFIED E. COU-MYCOBACTERIAL SHUTTLE VECTOR 
3.4.1. EVALUATION OF GFP EXPRESSION LEVELS 
levels are tu"",..::.II" low in E. my<:obi:.lctE!rlal shuttle Recombinant ",nl-'""..... p'vnrp" .. :inn 
vectors, In addition to Inrr"':::I,"1 recombinant levels 
of the recombinant gene an increase in copy number has been shown to 
increase recombinant """'"1""""" ""\lnr",.,,:::inn 
has fluorescent nrl'.n",rti",c which allow it to be visualised under UV 
been used as a marker for gene ",vr'rA,::C:il'.n 
3.4.1.1. GFP Fluorescence 
it has 
et 
The of GFP to fluoresce under UV was to a crude 
indication of whether the final modified vector exhibited increased recombinant 
and to determine which modifications M. 
and BCG were transformed final modified vector 
unmodified vector and modified intermediate vectors and 
oS(;600. Recombinant M. and BCG colonies were viewed under UV 
to visualise relative levels of GFP fluorescence. Fluorescent rM. 5megl7lill75 
colonies are shown in 3.10. and 3.11. Due to the nature 
of this relative GFP fluorescence levels were recorded as either 'low' or 
. Results are tabulated in Table 3.3. for rM. colonies and in Table 3.4. for 
rBCG 
Observed in fluorescence do not I'",n, .. ",c",nt definitive differences in GFP 
as there are limitations to this fluorescence intensities were not 
evaluated 
for such as 
as observational. conditions 











Figure 3.10. GFP Fluorescence of rM. smegmatiscolonies viewed under UV light. 
i- rM. smegmatis [pSG400] colonies; expression vector SG400 contains the high copy 
number mutation, ii- rM. smegmatis [pSG500] colonies; expression vector pSG500 contains 
the high copy number mutation and the entire rap gene including its putative terminator, iii-
rM. smegmatis [pRC100] colonies; pRC100 is the unmodified expression vector, iv- rM. 
smegmatis [pSG600] colonies; expression vector pSG600 contains the high copy number 
mutation and the hsp60 terminator following repB, v- rM. smegmatis [pSG300] colonies; fully 
modified expression vector pSG300 contains the high copy number mutation, the entire rap 
gene including its putative terminator, and the hsp60 terminator following repB. 
Table 3.3. Comparison of GFP Fluorescence of recombinant M. smegmatiscolonies 























Figure 3.11. GFP Fluorescence of rBCG ApanCOcolonies viewed under UV light. 
i- rBCG f'..panCD [pSG400] colonies; expression vector pSG400 contains the high copy number 
mutation, ii- rBCG f'..panCD [pSG500] colonies; expression vector pSG500 contains the high 
copy number mutation and the entire rap gene including its putative terminator, iii- rBCG 
f'..panCD [pRC100] colonies; pRClOO is the unmodified expression vector, iv- rBCG f'..panCD 
[pSG600] colonies; expression vector pSG600 contains the high copy number mutation and 
the hsp60 terminator following repB, v- rBCG f'..panCD [pSG300] colonies; fully modified 
expression vector pSG300 contains the high copy number mutation, the entire rap gene 
including its putative terminator, and the hsp60terminator following repS. 
Table 3.4. Comparison of GFP Fluorescence of recombinant BCG ~panCOcolonies 























rates may have varied among recombinants. colonies which may have 
been different of could be characterised different rates 
d~ dM b 
have been shown to vary in "'V,~,.",.:cil"\n level between and ct""tk\n;".'V 
observed differences in fluorescence may reflect 
different rather than differences in ",,,,,,·o.:,,,il"'" levels. 
In M. 5m,eor,natJfs. GFP fluorescence of colonies modified vector ..., ... '" ........ 'v 
n",r,t'\,.n,,,,t1 with the unmodified vector 
colonies copy number intermediate 
vector "' ... ,,,-.,,'v 
rM.smeor,nal~ U'''~J'VV 
did not appear to fluoresce with nr~'::Ih~r in,t",nc:iru than unmodified 
colonies. Both rM sm,ear,nac.ls ..., • .,"' .... 'vv I and colonies 
3.10.ii and copy number intermediate vectors with full rap and its 
and the terminator after 
GFP fluorescence relative to unmodified rM <;;memnat1s LJI!'I. ..... ,LVV 
exhibited increased 
colonies. 
As in M. rBCG the modified OV'''I,.""c:cir\n vector 
f1uoresoed with than unmodified rBCG l..l/JC;U,,-,V 
Recombinant BCG colonies copy 
number intermediate vector 3. showed an in 
fluorescence to those transformed with unmodified vector In contrast to M. 
nO\l~ev~=r, rBCG colonies the full 
terminator in addition to the copy number mutation did not 
appear to fluoresce with increased to unmodified rBCG tllJl7lJL,lj 
colonies. Colonies ty" .. t""inirln ..., •• ""./vv the intermediate ",vr\,.",.:cir.n 
vector characterised the copy number mutation and terminator 
<:nI,;oV!I:'n a clear increase in fluorescence relative to rBCG 
colonies. 
3.4.1.2. GFP Westem Blot An;llvs,ls 
Since n,-",,,,rn"''''lni GFP fluorescence results that some of the modifications made to 
the conferred an increase in GFP relative GFP 
more Western blot 











/).panCD protein samples probed with GFP-specific antibody. Protein samples utilised as well 
as their experimental functions are outlined in figure legends. 
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Figure 3.12. GFP Western Blot Analysis of rM. smegmatis protein samples. 
Cell lysate was obtained from log phase rM. smegmatis cultures and loaded into lanes as 
follows: lane 1- 1O~1 Kaleidoscope Protein Marker, lane 2- 15ng purified GFP (positive 
control), lane 3- 2~lg rM. smegmatis [pHS207] protein (high GFP-expressing positive 
control), lane 4- 2~g rM. smegmatis [pHS200] protein (GFP-free negative control), lane 5-
2~g rM. smegmatis [pRClOO] protein (unmodified vector), lane 6- 2~g rM. smegmatis 
[pSG400] protein (intermediate vector with high copy number mutation), lane 7- 2~g rM. 
smegmatis [pSG500] protein (intermediate vector containing full length rap and its putative 
terminator and high copy number mutation), lane 8- 2~g rM. smegmatis [pSG600] protein 
(intermediate vector containing hsp60 terminator following repS and high copy number 
mutation), lane 9- 2~g rM. smegmatis [pSG300] protein (fully modified vector), lane 10-
1Of.l1 Kaleidoscope Protein Marker. A GFP-specific antibody was used to probe membranes. 
The arrow indicates protein bands of approximately 27 kOa, correlating to the size of GFP. 
Positive and negative controls gave anticipated results in the Western blot analysis of rM. 
smegmatis samples. The GFP-specific antibody recognised a protein band of approximately 
27 kOa, correlating to the size expected for GFP, in purified GFP (Fig. 3.12. Lane 2) and high 
GFP-expressing rM. smegmatis [pHS207] (Fig. 3.12. Lane 3) positive controls. GFP-free rM. 
smegmatis[pHS200] (Fig. 3.12. Lane 4), utilised as a negative control, did not react with the 
GFP antibody. The 27 kOa band corresponding to GFP was detected in all experimental rM. 
smegmatis protein samples (Fig. 3.12. Lane 5-9). While absent from the purified GFP positive 
control (Fig. 3.12. Lane 2), an additional slew of smaller bands was consistently detected in 











is characterised as stable et 
have occurred 
these additional bands are 
extraction as additional bands 
are nr"":"' .... 1- in all recombinant M. sm,egfnal7s c: .. nr,I",c: ",vr, .. "","';,..n but not in the GFP 
standard. the smaller may rpnrp<::Jl'lnt GFP that has been 
truncated. The gene which was available for inclusion in vectors in this was 
modified for use in Ar.'1blltOp;sis thaliana. It has a G-C content of 
mycoilacteria which are h/nir::.II\I G-C rich. lJ.rr" .. rliinnl" A-T rich residues may 
















Calculated using the Codon Usage Analysis Tool of The Institute for Genomic Research (TIGR, 2007) 
The relative inh:>nc:i'hl of the GFP in ",,, .. ,,,, .. iIMO''''''::'' ""lI'lnnlt,." revealed differences in 
levels of GFP ovr,r",.:c:ir.n between vectors. Recombinant M. smeQlnalis rt)SGi30101 
the PVf"lrp'c:c:irln vector showed the most marked increase in 
GFP band inh:.nciru r, ... mr,::. ... ,rl to rM. smeolnatts the unmodified vector 
3.12. lane 
3.12. lane 
Recombinant the intermediate ovr, .. o.:", ... n vectors 
all to exhibit an increased GFP band relative to 
unmodified rM. smeolnalts IJ''''-',LVV 
observed for r M. ,<;;m,eat:nafj~<;; IJ."'U-TVV 
The lowest increase in relative GFP band int'::'nc:i'ru was 
with the 
demonstrated 
copy number mutation. A 
rM. 
intermediate vector characterised the 
rap and its I.IUlaLl~'C terminator. In 
relative to unmodified rM. ,<;;mealnalt<;; 
3.12. lane the intermediate vector 
increase in relative band nToncl11'V was 
3.12. lane which contained the 
copy number mutation in addition to the full 
I'1r".",1-<3r increase in GFP band Int'::'ndltv 
was evident for rM. sm,eafnallS [~)SG,601)] 
3.12. lane which contained the intermediate vector modified to include the copy 
number mutation and the Western blots nnl,rt".rI the 
of results. Silver c!'::.ini",... of repluca1te SOS-PAGE confirmed that all rM. 






















Figure 3.13. GFP Western Blot Analysis of rBCG l1.panCD protein samples. 
Cell lysate was obtained from log phase rBCG f'..panCD cultures and loaded into lanes as 
follows: Lane 1- 1O~1 Kaleidoscope Protein Marker, Lane 2- 15ng purified GFP (positive 
control), Lane 3- 2/lg rBCG f'..panCD [pHS207] protein (high GFP-expressing positive control), 
Lane 4- 2~g rBCG f'..panCD [pHS200] protein (GFP-free negative control), Lane 5- 2/lg rBCG 
f'..panCD [pRC100] protein (unmodified vector), Lane 6- 2/lg rBCG f'..panCD [pSG400] protein 
(intermediate vector with high copy number mutation), Lane 7- 2~g rBCG f'..panCD [pSG500] 
protein (intermediate vector containing full length rap and its putative terminator and high 
copy number mutation), Lane 8- 2/lg rBCG f'..panCD [pSG600] protein (intermediate vector 
containing hsp60 terminator following repS and high copy number mutation), Lane 9- 2/lg 
rBCG f'..panCD [pSG300] protein (fully modified vector), Lane 10-10/l1 Kaleidoscope Protein 
Marker. A GFP-specific antibody was used to probe membranes. The arrow indicates protein 
bands of approximately 27 kDa, correlating to the size of GFP. 
GFP Western results for rBCG f'..panCD were largely consistent with rM. smegmatis results. 
Positive and negative controls behaved as anticipated in the Western blot analysis of rBCG 
f'..panCD samples. The GFP-specific antibody recognised a protein band of approximately 27 
kDa, correlating to the size expected for GFP, in purified GFP (Fig. 3.13. Lane 2) and high 
GFP-expressing rBCG f'..panCD [pHS207] (Fig. 3.13. Lane 3) positive controls. The GFP-free 
rBCG f'..panCD [pHS200] (Fig. 3.13. Lane 4), which was utilised as a negative control, did not 
react with the antibody to GFP. The 27 kDa band corresponding to GFP was detected in all 
experimental rBCG f'..panCD protein samples (Fig. 3.13. Lane 5-9). Aside from the 27 kDa GFP 
band detected, a number of additional bands were conSistently detected in all GFP-expressing 
rBCG f'..panCD protein samples (Fig. 3.13. Lane 3 and 5-9). In addition to the 27 kDa band 
anticipated for GFP, additional larger bands were seen in all GFP-expressing BCG f'..panCD 











protein binding, as no such bands are seen in the negative control, which lacks the gfp gene 
but is otherwise identical to other BCG I'lpanCD samples. Furthermore, the additional bands 
vary in intensity proportionally to the 27 kDa band. One possible explanation for the 
additional band positioned slightly above the 50 kDa molecular weight is that it represents a 
54 kDa GFP dimer. In vitro dimerisation of 27 kDa GFP subunits has been previously noted 
(Hofmann et al, 2002). The band of approximately 37 kDa cannot be explained. In contrast to 
M. smegmatis, relative to the 15ng standard, GFP expression levels in the BCG I'lpanCD 
Western blot appeared generally higher than levels determined by ELISA. This may be 
explained by the fact that although the concentration of the purified GFP used as a standard 
was stated as equal between aliquots by the supplier, subsequent dot blot analysis revealed 
an inconSistency between aliquots utilised in the rM. smegmatis and BCG I'lpanCD Western 
blots (Data not shown). This adds further weight to interpreting Western blot results 
qualitatively as opposed to semi-quantitatively. 
The relative intenSity of the GFP protein band in experimental samples revealed differences in 
levels of GFP expression among vectors. Recombinant BCG I'lpanCD [pSG300] containing the 
fully modified expression vector (Fig. 3.13. Lane 9) showed the most considerable increase in 
GFP band intenSity compared to rBCG I'lpanCD [pRC100] which contained the unmodified 
vector (Fig. 3.13. Lane 5). Recombinant samples containing the intermediate expression 
vectors (Fig. 3.13. Lane 6-8) all exhibited a greater GFP band intenSity than unmodified rBCG 
I'lpanCD [pRC100]. The least substantial increase in relative GFP band intenSity was observed 
for rBCG I'lpanCD [pSG400] (Fig. 3.13. Lane 6) harbouring the intermediate vector modified 
to high copy number. A further increase in relative band intensity was demonstrated by rBCG 
I'lpanCD [pSGSOO] (Fig. 3.13. Lane 7) which contained the intermediate vector with the high 
copy number mutation and the full length rap and its putative terminator. Relative to 
unmodified rBCG I'lpanCD [pRClOO], an even greater increase in GFP band intensity was 
evident for rBCG I'lpanCD [pSG600] (Fig. 3.13. Lane 8) which contained the intermediate 
vector modified to include the high copy number mutation and the hsp60 terminator after 
repB. Duplicate Western blots supported result reproducibility. Silver staining of replicate 
SDS-PAGE gels confirmed that all rBCG I'lpanCD protein samples were loaded in equal 











3.4.1.3. GFP Capture ELISA 
Seeing as qualitative Western blot analysis confirmed relative differences in GFP expression 
levels among recombinant mycobacteria, levels of GFP expression were further analysed by 
quantitative GFP capture ELISA. The amount of GFP expressed by rM. smegmatis and rBCG 
/j.panCD protein samples is shown in Figure 3.14. and 3.15. respectively. Protein samples 
utilised as well as their experimental functions are outlined in figure legends. 
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Figure 3.14. GFP Expression Levels of rM. smegmatis Samples Based on Capture 
ELISA. 
Protein obtained from log phase rM. smegmatis cultures was used for GFP capture ELISA. 
Levels of GFP in samples were quantitated by extrapolation against a standard curve of 
known amounts of purified GFP protein. The amount of GFP expressed by rM. smegmatis 
protein samples is represented by bars coloured as follows: 0 - rM. smegmatis [pHS207] 
(high GFP-expressing positive control), • - rM. smegmatis [pHS200] (GFP-free negative 
control),D - rM. smegmatis [pRClOO] (unmodified vector), I!l - rM. smegmatis [pSG400] 
(intermediate vector with high copy number mutation), • - rM. smegmatis [pSG500] 
(intermediate vector containing full length rap and its putative terminator and high copy 
number mutation), • - rM. smegmatis [pSG600] (intermediate vector containing hsp60 
terminator following repS and high copy number mutation), D - rM. smegmatis [pSG300] 
(fully modified vector). Error bars represent the degree of variability between triplicate 
samples. Statistical Significance of differences in expression levels is indicated above pairwise 
lines joining compared samples. 
For both rM. smegmatis and rBCG /j.panCD capture ELISA experiments, the included positive 
and negative controls gave expected results. High amounts of GFP were detectable in positive 











( 0 in Fig. 3.14. and Fig. 3.15. respectively). No significant level of GFP was detected in 
negative controls r M. smegmatis and rBCG L'lpanCD containing the non GFP-expressing vector 
pHS200 ( • in Fig. 3.14. and Fig. 3.15. respectively). The GFP standard curve was shown to 
be linear up to an amount of lOng of GFP protein. For quantitation accuracy all samples were 
diluted as necessary, to fall within this linear range. Depicted error bars show little variability 
between triplicate samples suggesting that these results are reproducible. 
In M. smegmatis, the fully modified vector pSG300 ( 0 in Fig. 3.14) expressed the greatest 
amount of GFP of all rM. smegmatis experimental samples. At a concentration of 8.1% of 
total protein, this represented a four-fold increase in expression compared to the 2.1% of 
total protein expressed by unmodified rM. smegmatis [pRClOO] ( 0 in Fig . 3.14) with 
statistical significance of p<0.005. This result supports trends identified in fluorescence and 
Western blot studies in which rM. smegmatis [pSG300] exhibited the greatest GFP expression 
levels. Recombinant M. smegmatis [pSG400] ( m in Fig. 3.14) containing the intermediate 
vector characterised by the high copy number mutation behaved similarly to unmodified rM. 
smegmatis [pRC100], expressing GFP at a concentration of 2.0% per total protein. This 
confirms preliminary GFP fluorescence observations in which both rM. smegmatis [pRC100] 
and [pSG400] were recorded as low fluorescers. Interestingly, this capture ELISA datum 
disagreed with the qualitative GFP Western blot analysis which suggested that its GFP 
expression levels were greater than rM. smegmatis [pRC100] levels. A GFP expression level of 
4.7% of total protein was determined for rM. smegmatis [pSG500] ( • in Fig. 3.14) 
containing the intermediate vector with the high copy number mutation and the full length 
rap and putative terminator. This correlated to a two-fold increase in GFP expression 
compared to unmodified rM. smegmatis [pRC100] with statistical significance of p<0.005, 
supporting both fluorescence and Western blot studies. Recombinant M. smegmatis 
[pSG600], harbouring the intermediate vector modified to high copy number and 
incorporating the hsp60 terminator after repB, expressed GFP at a concentration of 6.3% per 
total protein ( II in Fig. 3.14). This corresponds to a three-fold increase in expression 
relative to unmodified rM. smegmatis [pRClOO] at a statistical significance of p<0.0005. This 
result supports both preliminary fluorescence observations recording rM. smegmatis [pSG600] 
as a high fluorescer and subsequent Western blot findings that rM. smegmatis [pSG600] had 
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Figure 3.15. GFP Expression Levels of rBCG ~panCDSamples Based on Capture 
ELISA. 
58 
Protein obtained from log phase rBCG 6.panCD cultures was used for GFP capture ELISA. 
Levels of GFP in samples were quantitated by extrapolation against a standard curve of 
known amounts of purified GFP protein. The amount of GFP expressed by rBCG 6.panCD 
protein samples is represented by bars coloured as follows: 0 - rBCG 6.panCD [pHS207] 
(high GFP-expressing positive control), • - rBCG 6.panCD [pHS200] (GFP-free negative 
control), 0 - rBCG 6.panCD [pRC100] (unmodified vector), Gl - rBCG 6.panCD [pSG400] 
(intermediate vector with high copy number mutation), • - rBCG 6.panCD [pSG500] 
(intermediate vector containing full length rap and its putative terminator and high copy 
number mutation), II - rBCG 6.panCD [pSG600] (intermediate vector containing hsp60 
terminator following repB and high copy number mutation), 0 - rBCG 6.panCD [pSG300] 
(fully modified vector). Error bars represent the degree of variability between triplicate 
samples. Statistical significance of differences in expression levels is indicated above pairwise 
lines joining compared samples. 
While gross trends observed for capture ELISA of rBCG 6.panCD samples were consistent with 
those noted for rM. smegmatis samples, fold differences in expression as well as actual levels 
of expression differed. The fully modified vector rBCG 6.panCD [pSG300] ( D in Fig. 3.15) 
expressed the greatest amount of GFP of rBCG 6.panCD experimental samples. At a 
concentration of 8.8% of total protein, this represents a fourteen-fold increase in expression 
compared to the 0.8% expressed by unmodified rBCG 6.panCD [pROOO] ( 0 in Fig. 3.15) 
with statistical significance of p<O.005. This result supports trends identified in fluorescence 
and Western blot studies in which rBCG 6.panCD [pSG300] exhibited the greatest level of GFP 
expression. Recombinant BCG 6.panCD [pSG400] ( EJ in Fig. 3.15) containing the 











unmodified rBCG /::'.panCD [pRC100], expressing GFP at 0.9% of total protein. This confirmed 
preliminary GFP fluorescence observations in which both rBCG [).panCD [pRClOO] and 
[pSG400] were recorded as low fluorescers. In contrast, this capture ELISA result 
contradicted the qualitative GFP Western blot analysis which suggested that rBCG [).panCD 
[pSG400] GFP expression levels were greater than rBCG [).panCD [pRC100] levels. A GFP 
expression level of 1.6% of total protein was determined for rBCG [).panCD [pSG500] ( • in 
Fig. 3.15) containing the intermediate vector with the high copy number mutation and the full 
length rap and putative terminator. This correlated to a two-fold increase in GFP expression 
compared to unmodified rBCG [).panCD [pRC100] with statistical significance of p<0.05, 
supporting both fluorescence and Western blot studies. Recombinant BCG [).panCD [pSG600], 
harbouring the intermediate vector modified to high copy number and incorporating the 
hsp60 terminator after repB, expressed GFP at a concentration of 8.5% per total protein 
( . in Fig. 3.15). This corresponded to a thirteen-fold increase in expression relative to 
unmodified rBCG [).panCD [pRC100] at a statistical significance of p<0.005. This datum 
supports both preliminary fluorescence observations recording rBCG [).panCD [pSG600] as a 
high fluorescer and subsequent Western blot findings that rBCG [).panCD [pSG600] had the 
second greatest level of expression. 
A disadvantage to the capture ELISA technique is that it measures in vitro levels of extracted 
protein. As such it depends on the premise that all proteins are isolated with equal 
efficiencies. Furthermore, protein samples are subject to degradation during isolation. 
Consequently, in vivo analysis of GFP expression levels is ideal and the fluorescent property 
of GFP permits this (Kremer et al, 1995). In this study, attempts to quantitate whole cell GFP 
expression levels using fluorimetry were abandoned due to technical problems with the 
fluorimeter which prevented a sensitive standard curve from being produced (Data not 
shown). 
3.4.2. EVALUATION OF VECTOR COpy NUMBER 
Determination of plasmid copy number was of interest for two reasons: first, to verify that 
incorporation of the high copy number mutation alone caused an increase in vector copy 
number, since GFP expression results revealed no notable improvement in expression, and 
second, to further investigate the effect of including the full length rap gene on copy number 











3.4.2.1. Restriction Digest Analysis 
To determine relative differences in plasmid copy number, rM. smegmatis and rBCG /:"panCD 
total DNA was digested using restriction enzymes, separated by gel electrophoresis, and 
subsequently analysed by densitometry. Gel electrophoresis images of separated total DNA 
samples and corresponding fold differences in the copy number of plasmids are depicted in 
Figure 3.16. and 3.17. respectively for rM. smegmatis, and in Figure 3.18. and Figure 3.19. 
respectively for rBCG /:,.panCD. 
As expected, the lowest plasmid copy number was observed for rM. smegmatis [pRC100] (0 
- in Fig. 3.17) harbouring the unmodified vector. Despite GFP expression results revealing no 
notable improvement in expression caused by incorporation of the high copy number 
mutation, an approximate two-fold increase in plasmid copy number relative to unmodified 
rM. smegmatis [pRC100] was observed for rM. smegmatis [pSG400] ( - in Fig. 3.17), 
containing the intermediate vector modified to include the high copy number mutation. A 
similar two-fold relative increase in copy number was revealed for rM. smegmatis [pSG600] 
( . - in Fig. 3.17) containing the intermediate vector with high copy number mutation and 
the hsp60 terminator downstream of repB. In comparison to the unmodified rM. smegmatis 
[pRC100], fully modified rM. smegmatis [pSG300] ( [] - in Fig. 3.17) and rM. smegmatis 
[pSGSOO] ( • - in Fig. 3.17) containing the intermediate vector with high copy number 
mutation in addition to the full length rap gene and its putative terminator demonstrated an 
increase in plasmid copy number of approximately four- and six-fold respectively. 
While trends observed for plasmid copy numbers of rBCG /:"panCD samples were consistent 
with those noted for rM. smegmatis samples, actual fold differences in copy numbers varied. 
As expected, the lowest plasmid copy number was observed for rBCG /:,.panCD [pRC100] ( 0 
- in Fig. 3.19) harbouring the unmodified vector. Although incorporation of the high copy 
number mutation did not improve GFP expression, an approximate two-fold increase in 
plasmid copy number relative to unmodified rBCG /:"panCD [pRC100] was observed for rBCG 
/:,.panCD [pSG400] ( - in Fig. 3.19), containing the intermediate vector modified to include 
the high copy number mutation. Similarly, a two-fold relative increase in copy number was 
noted for rBCG /:,.panCD [pSG600] ( . - in Fig. 3.19) containing the intermediate vector with 
high copy number mutation and the hsp60 terminator downstream of repB. As suggested by 
Stolt and Stoker (Stolt & Stoker, 1996a), vectors containing the full length rap gene showed 
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Figure 3.16. Restriction Digest Analysis of rH. smegmatistotal DNA for copy 
number determination. 
61 
Total DNA was extracted from stationary phase rM. smegmatis cultures and digested with 
Mlu! and Xba! restriction enzymes. Doubling dilutions of restriction digest reactions were 
loaded alongside similarly digested corresponding plasmid DNA and molecular weight marker 
as follows: Lane 1, 10, 11 + 24- ,,-DNAI Pst! molecular weight marker, Lane 2- 300ng 
pRC100 plasmid DNA control, Lane 3- 4~g rM. smegmatis [pRC100J total DNA, Lane 4- 2~g 
rM. smegmatis [pRC100J total DNA, Lane 5- l~g rM. smegmatis [pRClOOJ total DNA, Lane 
6- 300ng pSG400 plasmid DNA control, Lane 7- 4~g rM. smegmatis [pSG400J total DNA, 
Lane 8- 2~g rM. smegmatis [pSG400J total DNA, Lane 9- l~g rM. smegmatis [pSG400J 
total DNA, Lane 12- 300ng pSG500 plasmid DNA control, Lane 13- 4!J.g rM. smegmatis 
[pSG500J total DNA, Lane 14- 2~g rM. smegmatis [pSG500J total DNA, Lane 15- l~g rM. 
smegmatis [pSG500J total DNA, Lane 16- 300ng pSG600 plasmid DNA control, Lane 17-
4~g rM. smegmatis [pSG600J total DNA, Lane 18- 2~g rM. smegmatis [pSG600J total DNA, 
Lane 19- l!J.g rM. smegmatis [pSG600J total DNA, Lane 20- 300ng pSG300 plasmid DNA 
control, Lane 21- 4~g rM. smegmatis [pSG300J total DNA, Lane 22- 2~g rM. smegmatis 
[pSG300J total DNA, Lane 23- l!J.g rM. smegmatis [pSG300J total DNA. Arrows depict the 



























Figure 3.17. Relative fold difference between plasmid copy number of rM. smegmatis 
samples. 
Bars are coloured to represent fold-differences between rM. smegmatis samples as follows: 0 -
rM. smegmatis [pRClOO] (unmodified vector), [!l - rM. smegmatis [pSG400] (intermediate vector 
with high copy number mutation), • - rM. smegmatis [pSG500] (intermediate vector containing 
full length rap and its putative terminator and high copy number mutation), - r M. smegmatis 
[pSG600] (intermediate vector containing hsp60 terminator following rep8 and high copy number 
mutation), 0 - rM. smegmatis [pSG300] (fully modified vector). 
modified rBCG llpanCD [pSG300] ( 0 - in Fig. 3.19) and rBCG llpanCD [pSG500] ( . - in Fig. 
3.19) containing the intermediate vector modified to high copy number in addition to the full 
length rap gene and its putative terminator exhibited an approximately four-fold increase in 
plasmid copy number. 
The obvious limitation to this analysis is that the accuracy of the ratios of plasmid DNA to 
chromosomal DNA relies on the premise that each is extracted with equivalent efficiencies, 
which may not necessarily be the case. In addition, ratios may be skewed if background 
smears of chromosomal DNA interfere with densitometric analysis, however, no degradation 
was visible in uncut total DNA samples analysed by gel electrophoresis. Because the 
restriction digest analysis was intended as a pilot for further investigation into copy number, 
it was performed singularly. As such, results cannot be interpreted independently, but did 
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Figure 3.18. Restriction Digest Analysis for rBCG dpanCDplasmid copy number 
determination. 
63 
Total DNA was extracted from stationary phase rBCG f'1.panCD cultures and digested with MluI 
and XbaI restriction enzymes. Doubling dilutions of restriction digest reactions were loaded 
alongside similarly digested corresponding plasmid DNA and molecular weight marker as 
follows: Lane 1, 10, 11 + 24- "-DNA/Pst! molecular weight marker, Lane 2- 300ng pRClOO 
plasmid DNA control, Lane 3- 4I-Lg rBCG f'1.panCD [pRClOO] total DNA, Lane 4- 2I-Lg rBCG 
f'1.panCD [pRClOO] total DNA, Lane 5- ll-Lg rBCG f'1.p nCD [pRC100] total DNA, Lane 6-
300ng pSG400 plasmid DNA control, Lane 7- 4I-Lg rBCG f'1.panCD [pSG400] total DNA, Lane 
8- 2J..lg rBCG f'1.panCD [pSG400] total DNA, Lane 9- 1i-lg rBCG f'1.panCD [pSG400] total DNA, 
Lane 12- 300ng pSG500 plasmid DNA control, Lane 13- 4J..lg rBCG f'1.panCD [pSG500] total 
DNA, Lane 14- 2J..lg rBCG f'1.panCD [pSG500] total DNA, Lane 15- 1J..lg rBCG f'1.panCD 
[pSG500J total DNA, Lane 16- 300ng pSG600 plasmid DNA control, Lane 17- 4J..lg rBCG 
f'1.panCD [pSG600] total DNA, Lane 18- 2J..lg rBCG f'1.panCD [pSG600J total DNA, Lane 19-
1I-Lg rBCG f'1.panCD [pSG600J total DNA, Lane 20- 300ng pSG300 plasmid DNA control, Lane 
21- 4i-lg rBCG f'1.panCD [pSG300J total DNA, Lane 22- 2J..lg rBCG f'1.panCD [pSG300] total 
DNA, Lane 23- 1i-lg rBCG f'1.panCD [pSG300J total DNA. Arrows depict the 3.016 kb plasmid 
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Figure 3.19. Relative fold difference between plasmid copy number of rBCG J1panCD 
samples. 
Bars are coloured to represent fold-differences between rBCG f:,.panCD samples as follows: D -
rBCG I1panCD [pRClOO] (unmodified vector), EI - rBCG I1panCD [pSG400] (intermediate vector 
with high copy number mutation), • - rBCG I1panCD [pSGSOO] (intermediate vector containing 
full length rap and its putative terminator and high copy number mutation), • - rBCG I1panCD 
[pSG600] (intermediate vector containing hsp60 terminator following rep8 and high copy 
number mutation), 0 - rBCG I1panCD [pSG300] (fully modified vector). 
3.4.2.2. Qualitative Real-Time PCR 
Since the pilot restriction digest analysis identified differences in plasmid copy number among 
recombinants, fold differences were confirmed by qualitative real-time PCR. Probe-primer sets 
with specificity to regions of the 165 chromosomal gene and GFP plasmid gene respectively, 
were utilised simultaneously in mulitplex PCR with rM. smegmatis and rBCG I1panCD total 
DNA as template. The I1Ct between the 165 and GFP Ct was calculated for each recombinant 
sample and used to estimate plasmid copy number relative to the unmodified recombinant. 
Relative differences are tabulated in Table 3.6. and Table 3.7. for rM. smegmatis and rBCG 
I1panCD respectively. Trends in fold differences calculated by real-time PCR were consistent 
with those determined by restriction enzyme analysis. In comparison, actual fold differences 
in vector copy number were generally slightly higher when real-time PCR was used. This may 
be explained by linearity differences between the techniques, since ethidium bromide used to 
visualise total DNA in the restriction digest analysis is known to have a linear threshold 
(Koekemoer et al, 1998), while all results generated by real-time PCR fell within a determined 
linear range. 
A significant increase in vector copy number of approximately 3.S-fold was seen relative to 












copy number vector rn.,t::.iinir, ... the 
the modified r M. smeglnatis 
., .. ".::tn, .. increase in relative copy number of 
different to fold differences calculated for r M. sm'ealnaiis 
65 
1"""'1"1",' .. ,,,,1",1"1.1"1 terminator 
IJ"."' .... ,JV I showed an even 
this was not <:In,n,rl,r::llrlrIV 
and 
v::Iri::lhi:lilv between uUI,,",,",CIlC results. Recombinant M. smearnatis 
due to 
the 
copy number vector which included the full 






Modified expression vector is shown boldface 
to unmodified rHo smear.natlfS 1J1"'''''JLVV of ::rort,nf'f'lV' 
1.00 
3.54 ± 1.28 
10,41 ± 3.77 
3.78 ± 1.37 
In BeG an ::.nr"· .... "irn::.I",,,I,j two-fold and 2.5-fold increase in copy number was 
observed for the copy number vector ..., .... , .. -.".v 
terminator rnllnWlnn 
and the copy number vector 
relative to the unmodified 
vector ...",,"-.. 'I.IV. The increases in vector copy number were rBCG 
rnn,t::llir,inn the 
modified rBCG 




Modified expression vector is shown boldface 
copy number vector with the full rap, and the 
which showed four- and five-fold 
1.00 
2.39 ± 0.58 
4.48 ± 1.08 











3.4.3. EVALUATION OF VECTOR FITNESS 
In a number of "~"'\''''';;''''' E coJl'-m!ya)ba!ctE!rial shuttle vectors have proven unstable 
M""1""rll",, et 99..(l;Hii!leseleler et et 
recombinant insltabiility is attributed to the or metabolic burden of 
the recombinant gene aimed to inviestiiqa1te whether the mYCO[ladte 
Two modifications were made to the 
myc:obactleria r""n,lir.."n with the aim of indusion of the full rap gene 
and its and introduction of the terminator downstream of 
Therefore modified vectors were evaluated in terms of fitness. 
Vector fitness can be measured in a number of ways. the fitness of vectors may be 
reflected in recombinant rate. Thus the less stress on the host 
the better the the stress on the host the 
worse the rate. Fitness can be ascertained either size or standard 
curves measured in over time. the 
fitness of vectors may be reflected their That the lower the metabolic burden 
of the their in their and vice versa. 
3.4.3,1. Growth Rate 
3.4.3.1.1. Size 
Since the size of colonies reflects their sizes were as a 
crude indication of whether the final modified vector exhibited 
increased relative fitness and which modifications It must be stated 
that sizes do not reflect rates in with 
because of their there exists a risk of two or more colonies 
form a unit which would an inaccurate size. 
size determination a more accurate invlestiaation into 
rates. 
M. smt"!gmatis and BeG were transformed with final modified vector 05(;3010, 
unmodified vector modified intermediate and 
Due to the nature of this relative sizes were 
recorded as either 'small' or • Results are tabulated in Table 3.8. for rM. 










any of the modifications made. In 
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In H. sizes were observed for the unmodified rH. 
and rH. 
converted to copy number. In "''''I'1,t-.. "",,1-
the intermediate vector 
sizes were noted for r M. 
smiegmaif/S colonies the modified vector ........ , ..... vv. rH. smegfnal1s f[)SG;SOIOl 
the intermediate vector with copy number mutation and full rap gene 
and its 
with 
terminator and rM. t;n.1Pr1m;;itit; 10''"''.:0'"'''''' the intermediate vector 
copy number mutation and the 
size observations an 
o", ..... "'.oeir'n levels since r H. sn.leaml'.,tfs ""'n"nl.,,, 
levels less than or to 2.0% of total 
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As in rM. smegmatis, relatively large colony sizes were observed for the unmodified rBCG 
t::,panCD [pRClOO] and rBCG t::,panCD [pSG400] containing the intermediate vector converted 
to high copy number. In addition, rBCG t::,panCD [pSG500], containing the intermediate vector 
with high copy number mutation and full length rap gene and its putative terminator, 
exhibited a large colony size contrasting with observations for the same recombinant in rM. 
smegmatis. Relatively small colony sizes were noted for rBCG t::,panCD colonies harbouring 
the fully modified vector pSG300 and rBCG t::,panCD [pSG600], harbouring the intermediate 
vector with high copy number mutation and the hsp60 terminator downstream of repB, as 
observed in M. smegmatis. These colony size observations support the possible correlation 
between colony size and expression levels noted for M. smegmatis in that rBCG t::,panCD 
samples with larger colony sizes had GFP expression levels less than or equal to 1.6% of total 
protein while samples with smaller colony size had expression levels greater than or equal to 
8.5% of total protein. 
3.4.3.1.2. Growth Curves 
Standard growth curves were carried out in triplicate for rM. smegmatis and rBCG t1.panCD to 
confirm preliminary indications of different growth rates based on colony size for evaluation 
of relative differences in vector fitness. Results are shown in Figure 3.20. for rM. smegmatis 
and in Figure 3.21. for rBCG t1.panCD. Although the risk of absorbancies being affected by 
mycobacterial clumping is especially high for growth curve studies (Meyers et al, 1998), 
depicted error bars show little variability between triplicate samples implying that results are 
reproducible. 
Little difference in growth rate was observed for rM smegmatis cultures during mid-log phase 
of growth, as indicated by the similarity of mid-log phase gradients. However, differences in 
culture early log phases were noted. Recombinant M. smegmatis [pRClOO] (-<>- - in Fig. 
3.20), containing the unmodified vector, and rM. smegmatis [pSG400] ( - in Fig. 3.20), 
containing the intermediate vector converted to high copy number, exhibited the fastest 
relative growth rates during early log phase. A lower early log phase growth rate was 
observed for rM. smegmatis [pSG500] ( """'- - in Fig. 3.20) containing the intermediate 
vector with high copy number mutation and full length rap gene and its putative terminator. 











[pSG600] ( __ - in Fig. 3.20), harbouring the intermediate vector with high copy number 
mutation and the hsp60terminator downstream of repE, and rM. smegmatis [pSG300] 
( -+:l- - in Fig. 3.20) containing the fully modified vector. During stationary phase the highest 
final OD was recorded for rM. smegmatis [pRC100] and rM. smegmatis [pSG400] while 
relatively lower endpoint ODs were recorded for rM. smegmatis [pSGSOO], rM. smegmatis 
[pSG600] and rM. smegmatis [pSG300]. The growth curve findings suggest a possible 
correlation between rate of growth in early log phase and GFP expression levels. During early 
log phase specifically, lowest GFP-expressers rM. smegmatis [pRClOO] and rM. smegmatis 
[pSG400] exhibited faster growth rates while highest expressers rM. smegmatis [pSG600] 
and rM. smegmatis [pSG300] displayed slower growth rates. In addition, intermediary 
expresser rM. smegmatis [pSGSOO] also exhibited an intermediate growth rate. 
As in rM. smegmatis, rBCG t::,panCD cultures exhibited virtually no difference in mid-log phase 
growth rates. In contrast, differences were observed during early log phase growth and 
stationary phase. Recombinant BCG t::,panCD [pRC100] (-<)- - in Fig. 3.21), containing the 
unmodified vector, and rBCG t::,panCD [pSG400] ( - in Fig. 3.21), containing the 
intermediate vector converted to high copy number, exhibited the fastest early log phase 
growth rate. In comparison, the slowest early log phase growth rates were exhibited by rBCG 
t::,panCD [pSGSOO] (~ - in Fig. 3.21), containing the intermediate vector with high copy 
number mutation and full length rap gene and its putative terminator, rBCG t::,panCD 
[pSG600] ( --- - in Fig. 3.21), harbouring the intermediate vector with high copy number 
mutation and the hsp60terminator downstream of repE, and rBCG t::,panCD [pSG300] (-a- -
in Fig. 3.21), containing the fully modified vector. During stationary phase the highest final 
ODs were recorded for rBCG t::,panCD [pRC100], rBCG t::,panCD [pSG400] and rBCG t::,panCD 
[pSGSOO] while relatively lower endpoint ODs were recorded for rBCG t::,panCD [pSG600] and 
rBCG t::,panCD [pSG300]. The growth curve findings support a possible correlation between 
early log phase growth rate, endpoint ODs, and GFP expression levels. Specifically, lowest 
GFP-expressers rBCG t::,panCD [pRClOO], rBCG t::,panCD [pSG400] and rBCG t::,panCD 
[pSGSOO] exhibited the fastest early log phase growth rates and the highest endpoint 
absorbancies while highest expressers rBCG t::,panCD [pSG600] and rBCG t::,panCD [pSG300] 
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Figure 3.20. Standard growth curves of rM. smegmatiscultures. 
70 
50 60 
Coloured lines with markers represent the five rM. smegmatiscultures as follows: -<)... - rM. 
smegmatis [pRC100] (unmodified vector), - rM. smegmatis [pSG400] (intermediate 
vector with high copy number mutation), ....&- - rM. smegmatis [pSGSOO] (intermediate 
vector containing full length rap and its putative terminator and high copy number mutation), 
.-. - rM. smegmatis [pSG600] (intermediate vector containing hsp60 terminator following 














While recombinant studies a indication of how vectors contribute to 
metabolic it was necessary to determine the of vectors to further evaluate 
vector fitness. This has relevance for recombinant vaccine 
df'IJell:mrnerlt where vaccines are to be stable for up to twelve passages et 
To determine relative differences in cultures were grown in the 
absence of selection and every seven to an of 42 n<>,,<>r;:,r""lnc 
Due to time cultures were six times as this was suffident 
time for differences in recombinant to manifest. At each passage cultures 
were evaluated in terms of retention of antibiotic resistance and maintenance of GFP 
fluorescence. 
3.4.3.2.1. Antibiotic Resistance Retention 
The antibiotic resistance of r M. and rBCG \U'"'''tL,'''' cultures at each 
passage over 42 is shown in 3.22. and 
V;:,r'i.:>kilit\l of up to 30% for rM. and up to 50% for rBCG reflects a lack of 
Antibiotic resistance retention was determined antibiotic resistant 
units as a of total units. Mutations are random events as 
on 
variation between cultures is not 
of antibiotic resistance among passages 
mean 
of the 
accounts for some of the variation. The accuracy of this "'Vrll'lrillTll'll"lt relies 
numbers of rnrlmll"',1'1 units onto media Innl<>I'T,,,,nt,,,rl with antibiotic 
and antibiotic-free media. Because myc:obacb:!ria have a nrr.ne:>ncllt'\1 to volumes 
of culture dilutions may differ in count which may 
achieved. To accuracy, was considered as an alternative but was 
because further vector loss may occur the 20 additional 
formation. The use of 
""'IJU';;)'''I may the best alternative for antibiotic resistance since it limits 
incubation time and is of the number of units 
indications of antibiotic resistance are reliant on the formation of a confluent lawn of 
which may be difficult to achieve for which and 
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Figure 3.22. Kanamycin Resistance of rM. smegmatiscultures at multiple 
generations. 
74 
Duplicate cultures were passaged in the absence of selection over 42 generations. At each 
passage event, cultures were plated onto media containing and lacking kanamycin. Retention 
of kanamycin resistance was determined by recording colony counts from media containing 
kanamycin as a percentage of colony counts from kanamycin-free media. Graph i- rM. 
smegmatis [pRC100] (unmodified vector), ii- rM. smegmatis [pSG400] (intermediate vector 
with high copy number mutation), iii- r M. smegmatis [pSG500] (intermediate vector 
containing full length rap and its putative terminator and high copy number mutation), iv- rM. 
smegmatis [pSG600] (intermediate vector containing hsp60 terminator following repB and 
high copy number mutation), v- rM. smegmatis [pSG300] (fully modified vector). Error bars 
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Duplicate cultures were passaged over 42 generations, At each passage event, cultures were 
plated onto media containing and lacking kanamycin, Retention of kanamycin resistance was 
determined by recording colony counts from media containing kanamycin as a percentage of 
colony counts from kanamycin-free media, Graph j- rBCG 6.panCD [pRC100] (unmodified 
vector), ii- rBCG t::,panCD [pSG400] (intermediate vector with high copy number mutation), 
iii- rBCG 6.panCD [pSG500] (intermediate vector containing full length rap and its putative 
terminator and high copy number mutation), iy- rBCG 6.panCD [pSG600] (intermediate vector 
containing hsp60 terminator following repB and high copy number mutation), y - rBCG 
t::,panCD [pSG300] (fully modified vector), Error bars represent the degree of variability 











average of at least 90% ",;;o" ... ",vr.n resistance was observed for the first two passages after 
which resistance decreased to reach an of 65%. 
Recombinant BCG behaved to the unmodified 
for an :::'1'1',:::'1""1'11-
Recombinant rBCG u ..... "" ... ,L' 
mutation in addition to the 
v:::.r';>n'1\,ron resistance to 75% 
which contained the 
and rBCG 
the first passage. 
copy number 
were nifi(".::Int'lv less stable. For rBCG 
an initial resistance of 90% decreased to 60% 
the first and second passages. Resistance decreased to 10% the 
third passage after which no v:::.,,,,,",ur,.n resistance was observed. Recombinant BCG 
llJ"' ....... JUUJ showed initial resistance of 
resistance had decreased 
of antibiotic resistance 
between 0 and 15%. 
3.4.3.2.2 GFP Fluorescence Maintenance 
65%. the first passage, average 
to an average of 15%. Recorded 
passages were 
The maintenance of GFP fluorescence rM. sm,eQt:natfsand rBCG cultures at each 
passage over 42 is shown in 3.24. and 3.25. Without 
colonies formed on media SPli:iYf~U GFP fluorescence 
not This that observed was due to whole 
than 1"1""",,,,1-.1" r&'.::II','::>nnp.np,ntc: this was not verified 
I-nrm,,',1"1 units were therefore ,..p .... r""""'n .. M 
1""'1'""il"" units on results appear 
loss rather 
Fluorescent 
as the small sized error bars which rpn,,.pcIPnt v;:ori;:ohi,litv of less than 10% in all 
cases. This is due to the fact that fluorescent units were scored as a 
fn .. ,mi ... ,n units on the same antibiotic-free at each passage, 
and thus did not rlP'nPl'.rI on the fnl",mir,n unit counts between 
with and without antibiotic for accuracy. 
In rM. Sm,f:Qn7i1D:S, both the unmodified LI""~.L,""" vector and the copy number 
intermediate vector conferred the most in terms of GFP 
fluorescence maintenance. In both cases, the of GFP was 
rn,lci<:TP"tlv n"I'.;:oh>r than 85% at each passage. Recombinant M. smegfnatis 1.1 .... ,..." .. " 











its was less stable. Close to 100% of units 
fluoresced for the first passage after which of GFP fluorescence 
decreased per passage to reach a final GFP fluorescence of less than 5%. The least 
stabililty was observed for r M. .<;m,F"{Jlnal'ic; u .... ,,;.,,'vv rn.,t::liinirln the intermediate 
vector with the copy number mutation in addition to the terminator I"nllnW,nn 
modified rM. More than 90% of 
fnrmirln units exhibited GFP fluorescence the first passage with the n.<>rro,.,br,c 
fluorescence to over 40% at the second passage. A further 
drastic in GFP fluorescence to less than 10% was noted the third passage 
and fluorescence continued to decrease so that no colonies had maintained GFP 
fluorescence the end these observed differences in GFP 
fluorescence maintenance showed a correlation with results for studies of 
rates and levels. recombinants which were the most also grew 
the fastest and exhibited the lowest levels of GFP o"r,,·o.~cir .. ' 
Recombinant BCG C!U,:1I1l.U cultures different trends in the maintenance of GFP 
fluorescence to rH. cultures. Unmodified rBCG 
copy number rBCG UIJ'''IIl.V and intermediate rBCG 
which contained the number vector the entire rap 
gene and its were the most stable in terms of GFP fluorescence 
maintenance. All three recombinant cultures maintained a GFP fluorescence of at 
least 85% for the duration of the In intermediate rBCG LilA.II .... ..., 
rn","::>"nl,..,.., the copy number mutation and the terminator 
and modified rBCG I\Ll<711L.U rDISG~IOOl were the least stable. 
the very first passage, less than 40% of rBCG 1\'.k7I1LLJ r[)SGi60()1 colonies were 
the third passage, 5% of colonies GFP fluorescence after 
which no GFP fluorescence was observed. over 50% of rBCG UfJ';"" .... l/ OJ."'''','vv 
colonies were at the first passage. 5% of colonies exhibited GFP 
fluorescence the third passage after which no GFP fluorescence was detected. These 
results the correlation rate and 
level noted from data of rH. fluorescence maintenance. 
recombinants which were most stable also showed the fastest rates and had the 
lowest levels of GFP while less stable recombinants seemed to grow slower and 
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Figure 3.24. GFP Fluorescence of rM. smegmatiscultures at multiple generations. 
Duplicate cultures were passaged over 42 generations. At each passage event, cultures were 
plated onto media lacking kanamycin. Maintenance of GFP fluorescence was determined by 
recording counts of GFP fluorescing colonies as a percentage of total colony counts following 
visualisation of colonies under UV light. Graph i- rM. smegmatis [pRClOO] (unmodified vector), ii-
rM. smegmatis [pSG400] (intermediate vector with high copy number mutation), iii- rM. 
smegmatis [pSGSOO] (intermediate vector containing full length rap and its putative terminator 
and high copy number mutation), iv- rM. smegmatis [pSG600] (intermediate vector containing 
hsp60 terminator following repB and high copy number mutation), v- rM. smegmatis [pSG300J 
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4.1. GENERAL AIM 
This aimed to evaluate a series of modifications made to the myco[)aacenal 
most used in E. shuttle in terms of their effect on gene 
nl::,."rniti copy number and These modifications included: 
copy number mutation within inclusion of the entire rap 
gene and its 
terminator fnll,nwinn 
f-,.""ncr,rint'inn terminator and introduction of an 
4.2. MODIFICATION OF THE MYCOBACTERIAL REPLICON OF AN E. COU-
MYCOBACTERIAL SHUTTLE VECTOR 
bioinformatic did not reveal any intrinsic terminator sequences after 
the to most bioinformatics software is that searches for 
terminators are confined to structures. 
99.95°10 sequence between M. bovis and M. tuberculosis et the 
that a structured terminator may exist within this 
is since less than 1% of terminators within M. 
tuberculosis have a structure The 
terminator inserted downstream of consists of a 14 stem and a 5 a 
such a terminator is said to have an structure which of all 
identified termination sequences within M. tuberculosis have been to form. 
The sequence irlantilFi""rl bioinformatics as a terminator for the rap 
gene, has a 13 and a 5 terminator has 
been calculated as rPnr",c:.",ntinn """'iFf"" one tenth of termination structures found in 
M. tuberculosis 
between M. tuberculosis and 
Stolt and Stoker 
a IInrl,.,. ...... I,.. inverted 
.. "'nt,,,,t,, as the stem of a 
Based on the sequence hnrnnl,'V1v 
terminators may be common in BeG. In 
identified the stem of this as 












4.3. EVALUATION OF THE MODIFIED E. COU-MYCOBACTERIAL SHUTTLE VECTOR 
"",,,,Iir,,,, .. were to cause an 
4.3.1. EVALUATION OF GFP EXPRESSION LEVELS 
Two of the modifications made to the my(:ob.actE!ri 
increase in levels of recombinant gene pVflrp'_cin inclusion of both the 
copy number mutation and the full rap gene have been demonstrated to 
facilitate an increase in vector 
copy number would be reflected 
number. In it was suspec:ted that an increase in 
an increase in recombinant ",,,r\l·,,,.:,,;r.n levels. 
""''''' ....... 0<0'''''.. levels of the recombinant GFP were evaluated in this 
Levels of GFP in rM. and rBCG were ::In;<,IV<:!3n three t",rnn;,nI 
which served as a which a 
ELISA which 
the copy number mutation did not seem to correlate to an increase in 
",v,,,· .. ,:dr.n in rBCG ... /AUI .... ,V. C:iimill::lrl'iJ, neither the fluorescence nor the ELISA 
revealed the increase in GFP in rM. due to the 
copy number mutation. In rnrltr::l'Cr Western blot of rM. showed an 
::Inr');lr.:>nt increase in GFP as a result of copy number 
mutation. This in results for rM. the copy number 
mutation may be differences in conditions between the 
unmodified and modified M. Western Since ELISA is n<>" .. ",:>II\I 
considered a more sensitive and more accurate than Western GFP pvrlrp',C:irln 
levels are best reflected ELISA results for this besides the Western 
blot for rM. Sm'eGlnatts. pvr\r,:"~"irln results obtained the various t""rhni,nI 
confirmed that the copy number mutation did not confer the increase in 
recombinant GFP """r,,,,,,,:,,ir.n levels. 4rrn ... rliinnl\l this raised doubts as to whether an 
increase in DlasmlO copy number leads to a rnr .. ",,,,nnn,rli increase in GFP ",,,r,,,,,,,ocir.n 
As sU~ipe,ctelcl, n.·"'f"' ...... ".ti"'l inclusion of the full rap gene over its truncated 
form caused a increase in GFP <>"''''OIodrm levels. This result was observed for rM. 
sm,egl:nal7S and rBCG all with the of the fluorescence 
for 
evaluated 
colonies. '""""""~" an obvious increase in GFP levels 











in fluorescence int.:.ndlkl of rBCG ""V'''I1'''.'''' was noted inclusion of full rap, 
may be of detection norl"l"lit't'OI"I the Western blot and 
ELISA to the crude fluorescence the rap gene 
modification levels of GFP in rM. ',m,Mt:nPltit;than in rBCG ""1A'"I''',''' 
sUc:IClestlrlCl a DOSiSlDlle difference between M. sm~qt:nat.7S and BCG ldlA""""'"" at tl';,nc:/" ... in'~inr\;, 
nn<""_t'lr:::'n';::"u.nn ... level. A number of studies have also shown that 
levels vary among six of gene PVI1I'"p·<::<:irm 
genes were 
tuberculosis 
to be rlifl'lPl'",,'nti,:::Illv lP"''''I'"&><:<:&>t1 even In n&>r,&>tif"::Illlv similar M. bovis and M. 
et and et al demonstrated that 10% of 
common to both M. tuberculosis and BCG were at levels. 
Roberts et at up to two-fold "r.o'~l"lP" levels of 
GFP in rM. than in rM. tuberculosis transformed with identical 
pvr1r&>':;:<:irln vectors. Possible reasons for differential gene between M. sm,eQt:nal.IS 
and BCG may indude the fact that the M. is rnrl<:il1fpl'"~lhlv 
than the BCG genome and that M. ,t;mealnPltit; is an environmental 
nrt1l:::.niic:m whereas BCG is derived from M. bovis which is an intracellular n:::'I"'nn,,&>n 
Inr''' .. N ..... ''>t·'nn of the 
in both nvE!sti~;JatJed. This result was 
to increase 
as the 
modification was carried out for the purpose of nn::'V&>Ir'll"lr,n any pos;siblle 
of the recombinant gene. of into the 
lJ.f"r'nMlln"n, since the terminator was not introduced downstream of the gene, it was not 
eXI:leCted to affect GFP levels. The increase in GFP .ovr, .. """d",n 
one of two n"I'II'II'I",.<>c.:'" enhanced termination of may also increase the 
a stem-IIDDD 
t":>'r'lc,,-,rlnt'lnn terminator downstream of human A1u elements dnr\ifil"",ntl" increased their 
of Chu etal 
As 
may increase 
is a l'"::Itj~-lirTlitin( factor in nl:::l<;:mil1 repllica1tion 
which would increase GFP 
an increase in its 
Mo et at led to an increase in plasmid 
copy number. The second nVr'll'lI"I"I'<>C:IC: nr"""'""'Tlnln of interference with the 
of the recombinant gene enhanced of GFP o"", .. o.::c:II"" 
in the n .. """""nt ll-fold increase in levels of GFP &>vr1r&>·:;:<:irln was 











further ,d-.. ,~tinln that there exist differences at the tr::'incrrinf·inn::.1 or translational level 
between M. Smetllnac.,s BeG "'''-'0'' , .... ,-" 
4.3.2. EVALUATION OF VECTOR COpy NUMBER 
It was imrlnrt'::.nt to ascertain copy numbers were influenced the 
modifications Since this could account for the observed in GFP I'>'lfr,,'1'>'::<:i(',n 
the intended increase in copy number in this 
its terminator were included vector 
sU~lgested that in addition it may increase nl::.<:miin copy number &. 
increase in copy number would vectors 
GFP levels. the addition of the 
may have enhanced 
essential for ""::Iern.n .. ,> ... I;"'::It';n ... 
and therefore As is 
an increase in its abundance has been to increase 
copy number et which could the observed increase in GFP pvrlrp'::<:ir,n 
fnllnwinn indusion of the terminator. 
Relative differences in copy number were determined means of a 
restriction of total DNA and were ';''''1..''''''''-1'''<::' confirmed qUi~lI{i:lU,,'e real-
time PCR. A of variation was observed between fold differences in 
copy number. This variation may actual variation in ",I::.crnir! Since a 
UIJ"U:II,O:::; results two-fold difference in copy number has been ",,,",v.u.,,,,,,, rl'>nnrt~'n for 
of the same 
the copy number mutation a increase in copy 
which raises the as to double the per bacterium was not 
reflected a two-fold increase in GFP levels. one 
cvr'l~n,:::Iil'if'n for this is that the total DNA extraction ,.., .. n"n,.,I'\' c .. ":"-,' .. ",,,,, that cultures be 
late whereas all was extracted mid 
pvr,rl'>·::<:i(',n levels may have rl'> .. 're>':I'IntAfl a rnr"lI'><:lnnr,nin.n 
This would be as total DNA and 
also harvested Bourn et al 













Of all the modifications inclusion of the full rap gene and its 
nI"P::Itp'c:t increase in tl"::l11<::r1rintinn terminator within vectors facilitated the Llla:::llJl:IU copy 
that the rap gene does appear to 
This Stolt and Stoker 
number and offers an as to 
nrp:~h'>r GFP P'llr,rp·::.c:i('ln levels than those rnr'T'2,nl 
a role in copy number determination. 
which showed that rap influenced copy 
full rap exhibited 
truncated rap. the fold 
difference in copy number inclusion of the entire rap gene was c:inr,ifir'::Intlv 
for rM. than rBCG "'lA~II""L/which that the that rnrrpc:nnrll1irln 
differences in levels of GFP recorded for these mY~:ODactl:ma 
copy numbers is correct. The five- to ten-fold increase in copy number for rM. smeQl:natfs 
rBCG was reflected as a two-fold increase in GFP """'I"",.,,,lrln level. 
This non-direct between copy number and level may 
no increase in GFP P'llflI"P';:c:il'.n level was observed the 
copy number mutation the in copy number. 
Insertion of the terminator downstream of the gene in ",v."·",.,,,,rln 
vectors had no effect on plasmid copy number. This that the observed increase in 
GFP P'llr,rp'::.,.j(,ln is not the result of an increase in vector due to an increase in 
of inrl'I"I"lI'r::I!'inn of the facilitates an 
increase in the of recombinant 
terminator may enhance the """, .... ,,,,,,1"11"\1 
nov~ev~er that this nl""lnn.<:M is 
4.3.3. EVALUATION Of VECTOR fITNESS 
As discussed in the Introduction , __ ._,,_, 
recombinant mYloobactieria has 
aimed to whether the 
an alternative mechanism. For the 
nr""VP"Tllllt' interference with the 
gene. It must be emphclsised, 
and cannot be substantiated. 
much of the onus for varied of 
on the recombinant gene itself. This 
may also affect staDIIIl:V 
two modifications to the mYCot)adtenal .. ",.nli,rnn were made with the of 
and indusion of the full rap gene and 
introduction of the terminator downstream of Vector fitness was evaluated 











The copy number mutation did not reduce vector fitness in either rM. or 
rBCG L"';'ClI"'-~. This result confirms Bourn et at which showed that 
mVCOI)acterla transformed with the copy number vector were 
stable. inclusion of the entire rap gene did not affect fitness in rBCG 
when full rap was included within vectors in r M. 
<:ffl,Ptll:n;;;l:f<: a notable reduction in vector fitness was observed. In both rM. or 
rBCG ........ "1, .... ,'"' fitness was the introduction of the 
terminator downstream of a inverse correlation between vector 
fitness and GFP levels became evident. vector fitness was 
observed in recombinant characterised as while fitness 
was maintained in recombinant which exhibited lower levels of GFP ""''''''''':'11"''' 
Such a correlation could exist due to levels of recombinant ::mlrin"'n p£l{nrp<:c~inn which 
confer a metabolic load on the cell due to ::Inj'in".n or rare codon usage, 
gene utilised in this thus vector fitness. As stated in Section the 
was modified for use in An'lbil1oJ)'Sis thallana and thus contains codons which are 
In ".,.Uhhl" ..... much has been .. "nnrl"t>l1 on the inc:i,,,,nillihl of recombinant ",nt',n","1'" <>vn,'<>e.,<>rl 
the nlY'.m(',I'PI' in et 
Further work is necessary to determine whether the nrl".mr.t",,. incurs """'::II"~" 
levels of recombinant ::In!';"".n p'vn,.",cc:;nn 
decrease in with recombinant 
The observed 
may be overcome 
use of an inducible n,.".ml"'1I''''1'' which would allow ", ... ".",:>,,,,,,t';nn of recombinant cultures 
to cell in vitro while could then be induced to 
express levels of recombinant ::IInt'ln""n to or in 
on exposure of recombinant vaocines to the immune Two studies 
of for the with inducible ""('Im("'"",r<: to 
overcome The studies showed that HPV-ll 11 genes and the 
the rotavirus VP6 gene (n"'.""'~I'''1 were unstable when OVI"I",,~,t1 
nrl'1.mr,t"r within "''';<:I'I,n::l1 shuttle vectors in BCG, In both cases, was .m""",,":'" 
n .. ".mr.t", .. was substituted either the 18kOa or the mtrA 










4.4. GENERAL CONCLUSIONS 
In summary, this evaluated three modifications to the 




,:>vr, ... ,:>'::c::irin levels and stalbilltv: 
within inclusion of the entire rap gene and its 
copy number mutation 
t~I'Ic::rlrintinn terminator and 
introduction of an terminator t"nllnWlnn 
Tnr'nr .. ", ... ::>f"ir"., of a characterised copy number mutation et 
increased nl::.,.,,,,,II'; copy number in both M. and BCG which 
has for isolated from recombinant mycot)acteria 
The full rap gene and its truncated in 
were included in the vector in an to and 
increase GFP "V'~I"<>."c:iI'\n This modification conferred a increase in copy number in 
M. and BCG and would also be relevant to research 
of recombinant the 
modification was stable and is therefore useful for n':>\,,,,I,,,nl rBCG Ujj,Cllil~LrUCll;:>eU v::::Irrin&>c:: 
as recombinant vaccine ",lTlr!:ll'v has been shown to be enhanced an increase in .,v'~r.,.::<:ir\n 
levels of recombinant a increase in GFP was achieved 
in M. it was a considerable reduction in in the absence 
of antibiotic selection. 
An tl"::::Iln<:rrint'inn terminator was included downstream of the with the aim of 
this modification resulted mnrnv'Inn vector S(ClO1l111:V in M. and BCG 
in a severe decrease in "rhis reduction in a 
<:in,nifir::::lrlt increase in GFP This raised the of a correlation 
between recombinant levels and lower levels of E coli-
shuttle vectors which demonstrated levels of recombinant 
but were unstable in M. and BCG may still have ap~)IIC<:ltic)n 
in recombinant mycotladterial vaccines 
levels t",nnnr\r::::lliv 
While studies of vectors 
trends due to indusion of the full 
an inducible nrr,m("t",," to 
the recombinant GFP revealed 











future work is to establish whether similar results 
can be achieved when different recombinant genes are and whether vector 
could be codon of the recombinant gene for 
serves to confirm that modifications to the """'1"'::>,1\1 
utilised a role in levels of E. coli-
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